pathway_name,pathway_source,num_overlapping_genes,overlapping_genes,num_all_pathway_genes,P_genes,Q_genes,, Regulation of CDC42 activity,PID,4,GIT1_HUMAN;DOC10_HUMAN;BCAR3_HUMAN;DOCK9_HUMAN,30 (30),7.48E-05,0.344,0.000328947,152 Vitamin B12 Metabolism,Wikipathways,4,FA7_HUMAN;AACT_HUMAN;CUBN_HUMAN;HBA_HUMAN,50 (51),0.00056,0.587,, Semaphorin interactions,Reactome,4,COF1_HUMAN;MYH9_HUMAN;PLXA3_HUMAN;SEM6D_HUMAN,64 (64),0.00142,0.587,, Axon guidance,Reactome,9,ABL2_HUMAN;GIT1_HUMAN;PLXA3_HUMAN;CACB1_HUMAN;COF1_HUMAN;MYH9_HUMAN;SPTN5_HUMAN;SCN5A_HUMAN;SEM6D_HUMAN,356 (358),0.00156,0.587,, Erythrocytes take up oxygen and release carbon dioxide,Reactome,2,HBA_HUMAN;HBA_HUMAN,9 (9),0.002,0.587,, Cohesin Loading onto Chromatin,Reactome,2,NIPBL_HUMAN;PDS5B_HUMAN,10 (10),0.00249,0.587,, Scavenging of heme from plasma,Reactome,2,HBA_HUMAN;HBA_HUMAN,12 (12),0.00362,0.587,, O2/CO2 exchange in erythrocytes,Reactome,2,HBA_HUMAN;HBA_HUMAN,13 (13),0.00425,0.587,, hemoglobins chaperone,BioCarta,2,HBA_HUMAN;HBA_HUMAN,13 (13),0.00425,0.587,, D-myo-inositol (1_4_5)-trisphosphate degradation,HumanCyc,2,IMPA3_HUMAN;PI5PA_HUMAN,13 (13),0.00425,0.587,, extrinsic prothrombin activation pathway,BioCarta,2,FA5_HUMAN;FA7_HUMAN,13 (13),0.00425,0.587,, Erythrocytes take up carbon dioxide and release oxygen,Reactome,2,HBA_HUMAN;HBA_HUMAN,13 (13),0.00425,0.587,, Mitotic Telophase/Cytokinesis,Reactome,2,NIPBL_HUMAN;PDS5B_HUMAN,14 (14),0.00494,0.587,, Sema3A PAK dependent Axon repulsion,Reactome,2,COF1_HUMAN;PLXA3_HUMAN,16 (16),0.00645,0.587,, GPCR Dopamine D1like receptor,INOH,3,2ABB_HUMAN;GNAS1_HUMAN;CACB1_HUMAN,50 (50),0.00651,0.587,, EGFR1,NetPath,9,RHG42_HUMAN;TRI29_HUMAN;GIT1_HUMAN;TFG_HUMAN;COF1_HUMAN;AHNK_HUMAN;MYH9_HUMAN;ABL2_HUMAN;BCAR3_HUMAN,455 (457),0.00784,0.587,, RHO GTPases Activate ROCKs,Reactome,2,COF1_HUMAN;MYH9_HUMAN,19 (19),0.00905,0.587,, superpathway of D-myo-inositol (1_4_5)-trisphosphate metabolism,HumanCyc,2,IMPA3_HUMAN;PI5PA_HUMAN,20 (20),0.01,0.587,, Aminocaproic Acid Action Pathway,SMPDB,2,FA5_HUMAN;FA7_HUMAN,20 (20),0.01,0.587,, Tranexamic Acid Action Pathway,SMPDB,2,FA5_HUMAN;FA7_HUMAN,20 (20),0.01,0.587,, Alteplase Action Pathway,SMPDB,2,FA5_HUMAN;FA7_HUMAN,20 (20),0.01,0.587,, Urokinase Action Pathway,SMPDB,2,FA5_HUMAN;FA7_HUMAN,20 (20),0.01,0.587,, Reteplase Action Pathway,SMPDB,2,FA5_HUMAN;FA7_HUMAN,20 (20),0.01,0.587,, Streptokinase Action Pathway,SMPDB,2,FA5_HUMAN;FA7_HUMAN,20 (20),0.01,0.587,, Tenecteplase Action Pathway,SMPDB,2,FA5_HUMAN;FA7_HUMAN,20 (20),0.01,0.587,, Anistreplase Action Pathway,SMPDB,2,FA5_HUMAN;FA7_HUMAN,20 (20),0.01,0.587,, Aprotinin Action Pathway,SMPDB,2,FA5_HUMAN;FA7_HUMAN,20 (20),0.01,0.587,, Phenindione Action Pathway,SMPDB,2,FA5_HUMAN;FA7_HUMAN,20 (20),0.01,0.587,, Dicoumarol Action Pathway,SMPDB,2,FA5_HUMAN;FA7_HUMAN,20 (20),0.01,0.587,, Warfarin Action Pathway,SMPDB,2,FA5_HUMAN;FA7_HUMAN,20 (20),0.01,0.587,, Acenocoumarol Action Pathway,SMPDB,2,FA5_HUMAN;FA7_HUMAN,20 (20),0.01,0.587,, Coagulation ,SMPDB,2,FA5_HUMAN;FA7_HUMAN,20 (20),0.01,0.587,, Bivalirudin Action Pathway,SMPDB,2,FA5_HUMAN;FA7_HUMAN,20 (20),0.01,0.587,, Argatroban Action Pathway,SMPDB,2,FA5_HUMAN;FA7_HUMAN,20 (20),0.01,0.587,, Phenprocoumon Action Pathway,SMPDB,2,FA5_HUMAN;FA7_HUMAN,20 (20),0.01,0.587,, Dicumarol Action Pathway,SMPDB,2,FA5_HUMAN;FA7_HUMAN,20 (20),0.01,0.587,, Ximelagatran Action Pathway,SMPDB,2,FA5_HUMAN;FA7_HUMAN,20 (20),0.01,0.587,, Lepirudin Action Pathway,SMPDB,2,FA5_HUMAN;FA7_HUMAN,20 (20),0.01,0.587,, Ardeparin Action Pathway,SMPDB,2,FA5_HUMAN;FA7_HUMAN,21 (21),0.011,0.587,, Heparin Action Pathway,SMPDB,2,FA5_HUMAN;FA7_HUMAN,21 (21),0.011,0.587,, Fondaparinux Action Pathway,SMPDB,2,FA5_HUMAN;FA7_HUMAN,21 (21),0.011,0.587,, Enoxaparin Action Pathway,SMPDB,2,FA5_HUMAN;FA7_HUMAN,21 (21),0.011,0.587,, Glutamatergic synapse - Homo sapiens (human),KEGG,4,KCNJ3_HUMAN;GNAS1_HUMAN;GRM5_HUMAN;GRIK4_HUMAN,114 (114),0.0112,0.587,, Verapamil Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Disopyramide Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Procainamide (Antiarrhythmic) Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Fosphenytoin (Antiarrhythmic) Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Bopindolol Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Timolol Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Carteolol Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Bevantolol Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Practolol Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Dobutamine Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Isoprenaline Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Arbutamine Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Amiodarone Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Levobunolol Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Metipranolol Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Mexiletine Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Quinidine Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Sotalol Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Epinephrine Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Betaxolol Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Atenolol Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Alprenolol Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Acebutolol Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Muscle/Heart Contraction,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Diltiazem Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Propranolol Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Pindolol Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Penbutolol Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Oxprenolol Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Metoprolol Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Esmolol Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Bisoprolol Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Bupranolol Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Nebivolol Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Amlodipine Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Nitrendipine Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Nisoldipine Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Nimodipine Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Ibutilide Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Tocainide Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Flecainide Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Isradipine Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Nifedipine Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Felodipine Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Nadolol Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,61 (61),0.0112,0.587,, Carvedilol Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,62 (62),0.0118,0.6,, Labetalol Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,62 (62),0.0118,0.6,, Dengue-2 Interactions with Blood Clotting Cascade,Wikipathways,2,FA5_HUMAN;FA7_HUMAN,22 (22),0.012,0.608,, Lidocaine (Antiarrhythmic) Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,63 (63),0.0123,0.613,, ccr3 signaling in eosinophils,BioCarta,2,COF1_HUMAN;GNAS1_HUMAN,23 (23),0.0131,0.641,, Blood Clotting Cascade,Wikipathways,2,FA5_HUMAN;FA7_HUMAN,23 (23),0.0131,0.641,, Folate Metabolism,Wikipathways,3,FA7_HUMAN;AACT_HUMAN;HBA_HUMAN,65 (66),0.0134,0.645,, Plasmalogen biosynthesis,Reactome,1,ADAS_HUMAN,2 (2),0.0152,0.719,, UMP biosynthesis,HumanCyc,1,PYR1_HUMAN,2 (2),0.0152,0.719,, EPH-Ephrin signaling,Reactome,3,COF1_HUMAN;MYH9_HUMAN;GIT1_HUMAN,74 (74),0.0189,0.882,, Phase 2 - plateau phase,Reactome,2,CACB1_HUMAN;AKAP9_HUMAN,28 (28),0.0191,0.882,, Developmental Biology,Reactome,10,ABL2_HUMAN;GIT1_HUMAN;PLXA3_HUMAN;CACB1_HUMAN;COF1_HUMAN;DSG4_HUMAN;MYH9_HUMAN;SPTN5_HUMAN;SCN5A_HUMAN;SEM6D_HUMAN,618 (620),0.0192,0.882,, Vesicle-mediated transport,Reactome,10,HBA_HUMAN;MYO1C_HUMAN;SPTN5_HUMAN;TFG_HUMAN;FA5_HUMAN;EP15R_HUMAN;KIF11_HUMAN;NECP1_HUMAN;COPB2_HUMAN;HBA_HUMAN,620 (620),0.0196,0.891,, Interaction between L1 and Ankyrins,Reactome,2,SCN5A_HUMAN;SPTN5_HUMAN,29 (29),0.0205,0.92,, ER to Golgi Anterograde Transport,Reactome,4,FA5_HUMAN;SPTN5_HUMAN;COPB2_HUMAN;TFG_HUMAN,137 (137),0.0207,0.921,, Asparagine N-linked glycosylation,Reactome,6,SPTN5_HUMAN;TFG_HUMAN;FA5_HUMAN;SIA7F_HUMAN;COPB2_HUMAN;RD23B_HUMAN,286 (286),0.0221,0.965,, Heroin metabolism,Wikipathways,1,EST1_HUMAN,3 (3),0.0227,0.965,, Pyrimidine biosynthesis,Reactome,1,PYR1_HUMAN,3 (3),0.0227,0.965,, opposing roles of aif in apoptosis and cell survival,BioCarta,1,AIFM1_HUMAN,3 (3),0.0227,0.965,, Felodipine Metabolism Pathway,SMPDB,1,CACB1_HUMAN,3 (3),0.0227,0.965,, Adrenergic signaling in cardiomyocytes - Homo sapiens (human),KEGG,4,2ABB_HUMAN;GNAS1_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,144 (144),0.0243,1,, Heroin Action Pathway,SMPDB,2,EST1_HUMAN;CACB1_HUMAN,32 (32),0.0246,1,, WNT-Ncore,Signalink,2,CDC73_HUMAN;MACF1_HUMAN,32 (32),0.0246,1,, Phenytoin (Antiarrhythmic) Action Pathway,SMPDB,3,KCNJ3_HUMAN;SCN5A_HUMAN;CACB1_HUMAN,82 (82),0.0247,1,, Selenium Micronutrient Network,Wikipathways,3,FA7_HUMAN;AACT_HUMAN;HBA_HUMAN,82 (83),0.0247,1,, Glucagon-type ligand receptors,Reactome,2,GIPR_HUMAN;GNAS1_HUMAN,33 (33),0.0261,1,, Endothelin Pathways,Wikipathways,2,GNAS1_HUMAN;PYR1_HUMAN,33 (33),0.0261,1,, Calcium Regulation in the Cardiac Cell,Wikipathways,4,KCNJ3_HUMAN;GNAS1_HUMAN;ANXA6_HUMAN;CACB1_HUMAN,149 (149),0.0271,1,, African trypanosomiasis - Homo sapiens (human),KEGG,2,HBA_HUMAN;HBA_HUMAN,34 (35),0.0276,1,, myo-inositol de novo biosynthesis,HumanCyc,1,IMPA3_HUMAN,4 (4),0.0302,1,, Heroin Metabolism Pathway,SMPDB,1,EST1_HUMAN,4 (4),0.0302,1,, Fosphenytoin (Antiarrhythmic) Metabolism Pathway,SMPDB,1,SCN5A_HUMAN,4 (4),0.0302,1,, miR-222 in Exercise-Induced Cardiac Growth,Wikipathways,1,HMBX1_HUMAN,4 (4),0.0302,1,, G Protein Signaling Pathways,Wikipathways,3,KCNJ3_HUMAN;GNAS1_HUMAN;AKAP9_HUMAN,92 (92),0.0332,1,, Formation of Fibrin Clot (Clotting Cascade),Reactome,2,FA5_HUMAN;FA7_HUMAN,39 (39),0.0355,1,, Circadian entrainment - Homo sapiens (human),KEGG,3,KCNJ3_HUMAN;GNAS1_HUMAN;PER3_HUMAN,96 (96),0.0369,1,, HDL clearance,Reactome,1,CUBN_HUMAN,5 (5),0.0376,1,, Extrinsic Pathway of Fibrin Clot Formation,Reactome,1,FA7_HUMAN,5 (5),0.0376,1,, Pyruvate Carboxylase Deficiency,SMPDB,1,SYAM_HUMAN,5 (5),0.0376,1,, Primary Hyperoxaluria Type I,SMPDB,1,SYAM_HUMAN,5 (5),0.0376,1,, Capecitabine Action Pathway,SMPDB,1,EST1_HUMAN,5 (5),0.0376,1,, Lactic Acidemia,SMPDB,1,SYAM_HUMAN,5 (5),0.0376,1,, Capecitabine Metabolism Pathway,SMPDB,1,EST1_HUMAN,5 (5),0.0376,1,, Alanine Metabolism,SMPDB,1,SYAM_HUMAN,5 (5),0.0376,1,, Plasmalogen Synthesis,SMPDB,1,ADAS_HUMAN,5 (5),0.0376,1,, miRNA Biogenesis,Wikipathways,1,DGCR8_HUMAN,5 (5),0.0376,1,, Binding and Uptake of Ligands by Scavenger Receptors,Reactome,2,HBA_HUMAN;HBA_HUMAN,41 (41),0.0389,1,, Common Pathways Underlying Drug Addiction,Wikipathways,2,GNAS1_HUMAN;GRM5_HUMAN,41 (41),0.0389,1,, Transport to the Golgi and subsequent modification,Reactome,4,FA5_HUMAN;SPTN5_HUMAN;COPB2_HUMAN;TFG_HUMAN,168 (168),0.0395,1,, Inflammatory mediator regulation of TRP channels - Homo sapiens (human),KEGG,3,ASIC5_HUMAN;GNAS1_HUMAN;TRPA1_HUMAN,99 (99),0.0399,1,, Prostaglandin Synthesis and Regulation,Wikipathways,2,PRGC2_HUMAN;ANXA6_HUMAN,44 (44),0.0443,1,, Phase 0 - rapid depolarisation,Reactome,2,SCN5A_HUMAN;CACB1_HUMAN,44 (44),0.0443,1,, Axon guidance - Homo sapiens (human),KEGG,4,COF1_HUMAN;SEM6C_HUMAN;PLXA3_HUMAN;SEM6D_HUMAN,175 (175),0.0448,1,, tRNA modification in the mitochondrion,Reactome,1,HCD2_HUMAN,6 (6),0.0449,1,, Glibenclamide Action Pathway,SMPDB,1,CACB1_HUMAN,6 (6),0.0449,1,, Gliclazide Action Pathway,SMPDB,1,CACB1_HUMAN,6 (6),0.0449,1,, Intracellular Signalling Through PGD2 receptor and Prostaglandin D2,SMPDB,1,GNAS1_HUMAN,6 (6),0.0449,1,, Pancreas Function,SMPDB,1,CACB1_HUMAN,6 (6),0.0449,1,, Repaglinide Action Pathway,SMPDB,1,CACB1_HUMAN,6 (6),0.0449,1,, Nateglinide Action Pathway,SMPDB,1,CACB1_HUMAN,6 (6),0.0449,1,, Dopamine Activation of Neurological Reward System,SMPDB,1,GNAS1_HUMAN,6 (6),0.0449,1,, exRNA mechanism of action and biogenesis,Wikipathways,1,DGCR8_HUMAN,6 (6),0.0449,1,, Metal sequestration by antimicrobial proteins,Reactome,1,NGAL_HUMAN,6 (6),0.0449,1,, Post-translational protein phosphorylation,Reactome,3,MFGM_HUMAN;LAMB2_HUMAN;FA5_HUMAN,108 (110),0.0495,1,, Fatty Acid Elongation In Mitochondria,SMPDB,1,HCD2_HUMAN,7 (7),0.0522,1,, TYSND1 cleaves peroxisomal proteins,Reactome,1,ADAS_HUMAN,7 (7),0.0522,1,, Corticotropin Activation of Cortisol Production,SMPDB,1,GNAS1_HUMAN,7 (7),0.0522,1,, Vasopressin Regulation of Water Homeostasis,SMPDB,1,GNAS1_HUMAN,7 (7),0.0522,1,, Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD),SMPDB,1,HCD2_HUMAN,7 (7),0.0522,1,, DDX1 as a regulatory component of the Drosha microprocessor,Wikipathways,1,DGCR8_HUMAN,7 (7),0.0522,1,, Malaria - Homo sapiens (human),KEGG,2,HBA_HUMAN;HBA_HUMAN,49 (49),0.0537,1,, Rapid glucocorticoid signaling,PID,1,GNAS1_HUMAN,8 (8),0.0594,1,, Excitatory Neural Signalling Through 5-HTR 4 and Serotonin,SMPDB,1,GNAS1_HUMAN,8 (8),0.0594,1,, Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin,SMPDB,1,GNAS1_HUMAN,8 (8),0.0594,1,, Excitatory Neural Signalling Through 5-HTR 7 and Serotonin ,SMPDB,1,GNAS1_HUMAN,8 (8),0.0594,1,, Excitatory Neural Signalling Through 5-HTR 6 and Serotonin ,SMPDB,1,GNAS1_HUMAN,8 (8),0.0594,1,, Intracellular Signalling Through Histamine H2 Receptor and Histamine,SMPDB,1,GNAS1_HUMAN,8 (8),0.0594,1,, Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids,SMPDB,1,HCD2_HUMAN,8 (8),0.0594,1,, Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD),SMPDB,1,HCD2_HUMAN,8 (8),0.0594,1,, Role of ABL in ROBO-SLIT signaling,Reactome,1,ABL2_HUMAN,8 (8),0.0594,1,, Phase I biotransformations_ non P450,Wikipathways,1,EST1_HUMAN,8 (8),0.0594,1,, Effects of Nitric Oxide,Wikipathways,1,HBA_HUMAN,8 (8),0.0594,1,, Muscle contraction,Reactome,4,CACB1_HUMAN;SCN5A_HUMAN;ANXA6_HUMAN;AKAP9_HUMAN,195 (195),0.0619,1,, Antiarrhythmic Pathway_ Pharmacodynamics,PharmGKB,2,KCNJ3_HUMAN;SCN5A_HUMAN,55 (55),0.0659,1,, Sodium/Proton exchangers,Reactome,1,SL9A2_HUMAN,9 (9),0.0666,1,, Sulfur metabolism - Homo sapiens (human),KEGG,1,IMPA3_HUMAN,9 (9),0.0666,1,, signal dependent regulation of myogenesis by corepressor mitr,BioCarta,1,HDAC9_HUMAN,9 (9),0.0666,1,, Phase 3 - rapid repolarisation,Reactome,1,AKAP9_HUMAN,9 (9),0.0666,1,, Clopidogrel Pathway_ Pharmacokinetics,PharmGKB,1,EST1_HUMAN,9 (9),0.0666,1,, Thyroid hormone synthesis,SMPDB,1,DUOX1_HUMAN,9 (9),0.0666,1,, Transport of small molecules,Reactome,9,HBA_HUMAN;GNAS1_HUMAN;CUBN_HUMAN;SL9A2_HUMAN;ADDA_HUMAN;ASIC5_HUMAN;TRPA1_HUMAN;NGAL_HUMAN;HBA_HUMAN,665 (666),0.0668,1,, Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),Reactome,3,MFGM_HUMAN;LAMB2_HUMAN;FA5_HUMAN,125 (127),0.0703,1,, Vitamin D (calciferol) metabolism,Reactome,1,CUBN_HUMAN,10 (10),0.0737,1,, Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone,SMPDB,1,GNAS1_HUMAN,10 (10),0.0737,1,, Activation of Ca-permeable Kainate Receptor,Reactome,1,GRIK4_HUMAN,10 (10),0.0737,1,, Ionotropic activity of kainate receptors,Reactome,1,GRIK4_HUMAN,10 (10),0.0737,1,, Removal of aminoterminal propeptides from gamma-carboxylated proteins,Reactome,1,FA7_HUMAN,10 (10),0.0737,1,, regulation of spermatogenesis by crem,BioCarta,1,GNAS1_HUMAN,10 (10),0.0737,1,, Gamma-carboxylation of protein precursors,Reactome,1,FA7_HUMAN,10 (10),0.0737,1,, Intracellular Signalling Through LHCGR Receptor and Luteinizing Hormone/Choriogonadotropin,SMPDB,1,GNAS1_HUMAN,10 (10),0.0737,1,, Thyroxine biosynthesis,Reactome,1,DUOX1_HUMAN,10 (10),0.0737,1,, BMAL1-CLOCK_NPAS2 activates circadian gene expression,Wikipathways,1,FA7_HUMAN,10 (10),0.0737,1,, Platelet degranulation ,Reactome,3,COF1_HUMAN;FA5_HUMAN;AACT_HUMAN,128 (129),0.0744,1,, Complement and Coagulation Cascades,Wikipathways,2,FA5_HUMAN;FA7_HUMAN,59 (59),0.0745,1,, NCAM signaling for neurite out-growth,Reactome,2,SPTN5_HUMAN;CACB1_HUMAN,59 (59),0.0745,1,, Membrane Trafficking,Reactome,8,MYO1C_HUMAN;SPTN5_HUMAN;TFG_HUMAN;FA5_HUMAN;EP15R_HUMAN;KIF11_HUMAN;NECP1_HUMAN;COPB2_HUMAN,582 (582),0.0761,1,, Dengue-2 Interactions with Complement and Coagulation Cascades,Wikipathways,2,FA5_HUMAN;FA7_HUMAN,60 (60),0.0767,1,, Factors involved in megakaryocyte development and platelet production,Reactome,3,KIF11_HUMAN;DOC10_HUMAN;DOCK9_HUMAN,131 (131),0.0785,1,, Dopaminergic synapse - Homo sapiens (human),KEGG,3,KCNJ3_HUMAN;2ABB_HUMAN;GNAS1_HUMAN,131 (131),0.0785,1,, Cardiac conduction,Reactome,3,SCN5A_HUMAN;AKAP9_HUMAN;CACB1_HUMAN,131 (131),0.0785,1,, Alpha6 beta4 integrin-ligand interactions,PID,1,LAMB2_HUMAN,11 (11),0.0808,1,, Gamma-carboxylation_ transport_ and amino-terminal cleavage of proteins,Reactome,1,FA7_HUMAN,11 (11),0.0808,1,, regulation of eif2,BioCarta,1,E2AK4_HUMAN,11 (11),0.0808,1,, Establishment of Sister Chromatid Cohesion,Reactome,1,PDS5B_HUMAN,11 (11),0.0808,1,, Valproic Acid Metabolism Pathway,SMPDB,1,HCD2_HUMAN,11 (11),0.0808,1,, 3-oxo-10R-octadecatrienoate beta-oxidation,EHMN,1,HCD2_HUMAN,11 (11),0.0808,1,, Response to elevated platelet cytosolic Ca2+,Reactome,3,COF1_HUMAN;FA5_HUMAN;AACT_HUMAN,133 (134),0.0813,1,, Pathways Affected in Adenoid Cystic Carcinoma,Wikipathways,2,NSD1_HUMAN;MGAP_HUMAN,63 (63),0.0834,1,, RNA Polymerase II Transcription Elongation,Reactome,2,CDC73_HUMAN;RPB7_HUMAN,64 (65),0.0857,1,, Formation of RNA Pol II elongation complex ,Reactome,2,CDC73_HUMAN;RPB7_HUMAN,64 (65),0.0857,1,, P2Y receptors,Reactome,1,P2Y11_HUMAN,12 (12),0.0878,1,, isoleucine degradation,HumanCyc,1,HCD2_HUMAN,12 (12),0.0878,1,, Caspase-mediated cleavage of cytoskeletal proteins,Reactome,1,ADDA_HUMAN,12 (12),0.0878,1,, phospholipase c-epsilon pathway,BioCarta,1,GNAS1_HUMAN,12 (12),0.0878,1,, protein kinase a at the centrosome,BioCarta,1,AKAP9_HUMAN,12 (12),0.0878,1,, Josephin domain DUBs,Reactome,1,RD23B_HUMAN,12 (12),0.0878,1,, Dimethyl-branched-chain fatty acid mitochondrial beta-oxidation,EHMN,1,HCD2_HUMAN,12 (12),0.0878,1,, Trihydroxycoprostanoyl-CoA beta-oxidation,EHMN,1,HCD2_HUMAN,12 (12),0.0878,1,, Integrated Cancer Pathway,Wikipathways,1,PO2F1_HUMAN,12 (15),0.0878,1,, MicroRNA (miRNA) biogenesis,Reactome,1,DGCR8_HUMAN,12 (12),0.0878,1,, Beta-agonist/Beta-blocker Pathway_ Pharmacodynamics,PharmGKB,2,GNAS1_HUMAN;SL9A2_HUMAN,65 (66),0.088,1,, Transmission across Chemical Synapses,Reactome,4,KCNJ3_HUMAN;GRIK4_HUMAN;CACB1_HUMAN;AKAP9_HUMAN,224 (224),0.092,1,, BMAL1:CLOCK_NPAS2 activates circadian gene expression,Reactome,1,FA7_HUMAN,13 (13),0.0948,1,, role of mitochondria in apoptotic signaling,BioCarta,1,AIFM1_HUMAN,13 (13),0.0948,1,, attenuation of gpcr signaling,BioCarta,1,GNAS1_HUMAN,13 (13),0.0948,1,, TNFR1-induced proapoptotic signaling,Reactome,1,OTU7B_HUMAN,13 (13),0.0948,1,, Presynaptic depolarization and calcium channel opening,Reactome,1,CACB1_HUMAN,13 (13),0.0948,1,, Mycophenolic acid Pathway_ Pharmacokinetics/Pharmacodynamics,PharmGKB,1,EST1_HUMAN,13 (13),0.0948,1,, Irinotecan Pathway_ Pharmacokinetics,PharmGKB,1,EST1_HUMAN,13 (13),0.0948,1,, Ganglio Sphingolipid Metabolism,Wikipathways,1,SIA7F_HUMAN,13 (13),0.0948,1,, Irinotecan Pathway,Wikipathways,1,EST1_HUMAN,13 (13),0.0948,1,, Valproic acid pathway,Wikipathways,1,HCD2_HUMAN,13 (13),0.0948,1,, COPII-mediated vesicle transport,Reactome,2,FA5_HUMAN;TFG_HUMAN,69 (69),0.0973,1,, Loss of Nlp from mitotic centrosomes,Reactome,2,PCNT_HUMAN;AKAP9_HUMAN,69 (69),0.0973,1,, Loss of proteins required for interphase microtubule organization from the centrosome,Reactome,2,PCNT_HUMAN;AKAP9_HUMAN,69 (69),0.0973,1,, RNA polymerase II transcribes snRNA genes,Reactome,2,PO2F1_HUMAN;RPB7_HUMAN,70 (77),0.0997,1,, sumoylation by ranbp2 regulates transcriptional repression,BioCarta,1,HDAC9_HUMAN,14 (14),0.102,1,, SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion,Reactome,1,PLXA3_HUMAN,14 (14),0.102,1,, Synthesis of IP2_ IP_ and Ins in the cytosol,Reactome,1,PI5PA_HUMAN,14 (14),0.102,1,, Warfarin Pathway_ Pharmacodynamics,PharmGKB,1,FA7_HUMAN,14 (14),0.102,1,, Irinotecan Pathway_ Pharmacodynamics,PharmGKB,1,EST1_HUMAN,14 (14),0.102,1,, Inositol Phosphate Metabolism,SMPDB,1,PI5PA_HUMAN,14 (14),0.102,1,, Hypoacetylaspartia,SMPDB,1,PYR1_HUMAN,14 (14),0.102,1,, Aspartate Metabolism,SMPDB,1,PYR1_HUMAN,14 (14),0.102,1,, Canavan Disease,SMPDB,1,PYR1_HUMAN,14 (14),0.102,1,, Retrograde endocannabinoid signaling - Homo sapiens (human),KEGG,3,KCNJ3_HUMAN;NU4M_HUMAN;GRM5_HUMAN,148 (148),0.104,1,, AURKA Activation by TPX2,Reactome,2,PCNT_HUMAN;AKAP9_HUMAN,72 (72),0.105,1,, Primary Focal Segmental Glomerulosclerosis FSGS,Wikipathways,2,LAMB2_HUMAN;MYH9_HUMAN,72 (73),0.105,1,, GPCRs_ Class C Metabotropic glutamate_ pheromone,Wikipathways,1,GRM5_HUMAN,15 (15),0.109,1,, D-myo-inositol (1_3_4)-trisphosphate biosynthesis,HumanCyc,1,PI5PA_HUMAN,15 (15),0.109,1,, Glycosphingolipid biosynthesis - ganglio series - Homo sapiens (human),KEGG,1,SIA7F_HUMAN,15 (15),0.109,1,, EPHA-mediated growth cone collapse,Reactome,1,MYH9_HUMAN,15 (15),0.109,1,, Nucleobase biosynthesis,Reactome,1,PYR1_HUMAN,15 (15),0.109,1,, 1D-myo-inositol hexakisphosphate biosynthesis II (mammalian),HumanCyc,1,PI5PA_HUMAN,15 (15),0.109,1,, Valproic Acid Pathway_ Pharmacodynamics,PharmGKB,1,HDAC9_HUMAN,15 (17),0.109,1,, Pathway_PA165964473,PharmGKB,1,HDAC9_HUMAN,15 (17),0.109,1,, CREB phosphorylation through the activation of CaMKII,Reactome,1,AKAP9_HUMAN,15 (15),0.109,1,, superpathway of pyrimidine ribonucleotides de novo biosynthesis,HumanCyc,1,PYR1_HUMAN,15 (15),0.109,1,, Inositol phosphate metabolism - Homo sapiens (human),KEGG,2,IMPA3_HUMAN;PI5PA_HUMAN,74 (74),0.109,1,, Oxytocin signaling pathway - Homo sapiens (human),KEGG,3,KCNJ3_HUMAN;GNAS1_HUMAN;CACB1_HUMAN,152 (152),0.11,1,, Processing of Capped Intron-Containing Pre-mRNA,Reactome,4,SNUT2_HUMAN;SRRM2_HUMAN;RPB7_HUMAN;SLU7_HUMAN,240 (240),0.111,1,, Neurotransmitter receptors and postsynaptic signal transmission,Reactome,3,KCNJ3_HUMAN;GRIK4_HUMAN;AKAP9_HUMAN,153 (153),0.112,1,, LPA4-mediated signaling events,PID,1,GNAS1_HUMAN,16 (16),0.115,1,, Nucleotide-like (purinergic) receptors,Reactome,1,P2Y11_HUMAN,16 (16),0.115,1,, CRMPs in Sema3A signaling,Reactome,1,PLXA3_HUMAN,16 (16),0.115,1,, Mycophenolic Acid Metabolism Pathway,SMPDB,1,EST1_HUMAN,16 (16),0.115,1,, Glycosphingolipid biosynthesis - neolactoseries,EHMN,1,COPB2_HUMAN,16 (16),0.115,1,, Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways,Wikipathways,3,PRGC2_HUMAN;SCN5A_HUMAN;HDAC9_HUMAN,156 (159),0.117,1,, Human papillomavirus infection - Homo sapiens (human),KEGG,5,LAMB2_HUMAN;GNAS1_HUMAN;CHAD_HUMAN;HDAC9_HUMAN;2ABB_HUMAN,339 (339),0.117,1,, Complement and coagulation cascades - Homo sapiens (human),KEGG,2,FA5_HUMAN;FA7_HUMAN,79 (79),0.122,1,, Recruitment of NuMA to mitotic centrosomes,Reactome,2,PCNT_HUMAN;AKAP9_HUMAN,79 (79),0.122,1,, Twelve loci associated with ADHD,Wikipathways,1,SEM6D_HUMAN,17 (26),0.122,1,, prion pathway,BioCarta,1,LAMB2_HUMAN,17 (19),0.122,1,, y branching of actin filaments,BioCarta,1,ABL2_HUMAN,17 (17),0.122,1,, Butanoate metabolism,INOH,1,HCD2_HUMAN,17 (17),0.122,1,, Unblocking of NMDA receptor_ glutamate binding and activation,Reactome,1,AKAP9_HUMAN,17 (17),0.122,1,, Ras activation upon Ca2+ influx through NMDA receptor,Reactome,1,AKAP9_HUMAN,17 (17),0.122,1,, PKA activation in glucagon signalling,Reactome,1,GNAS1_HUMAN,17 (17),0.122,1,, Mycophenolic acid Pathway_ Pharmacokinetics,PharmGKB,1,EST1_HUMAN,17 (17),0.122,1,, Recruitment of mitotic centrosome proteins and complexes,Reactome,2,PCNT_HUMAN;AKAP9_HUMAN,80 (80),0.124,1,, Centrosome maturation,Reactome,2,PCNT_HUMAN;AKAP9_HUMAN,80 (80),0.124,1,, Signaling by Hedgehog,Reactome,2,CDC73_HUMAN;GNAS1_HUMAN,81 (82),0.127,1,, Cobalamin (Cbl_ vitamin B12) transport and metabolism,Reactome,1,CUBN_HUMAN,18 (19),0.129,1,, MET activates PTK2 signaling,Reactome,1,LAMB2_HUMAN,18 (18),0.129,1,, Amine-derived hormones,Reactome,1,DUOX1_HUMAN,18 (18),0.129,1,, Glycosphingolipid biosynthesis - globoseries,EHMN,1,COPB2_HUMAN,18 (18),0.129,1,, ECM-receptor interaction - Homo sapiens (human),KEGG,2,LAMB2_HUMAN;CHAD_HUMAN,82 (82),0.129,1,, COPI-dependent Golgi-to-ER retrograde traffic,Reactome,2,KIF11_HUMAN;COPB2_HUMAN,82 (82),0.129,1,, COPI-mediated anterograde transport,Reactome,2,COPB2_HUMAN;SPTN5_HUMAN,83 (83),0.132,1,, Hemostasis,Reactome,8,DOC10_HUMAN;FA5_HUMAN;FA7_HUMAN;AACT_HUMAN;COF1_HUMAN;DOCK9_HUMAN;KIF11_HUMAN;GNAS1_HUMAN,662 (668),0.132,1,, Pyrimidine metabolism,Wikipathways,2,RPB7_HUMAN;PYR1_HUMAN,84 (84),0.135,1,, Serotonin Receptor 4-6-7 and NR3C Signaling,Wikipathways,1,GNAS1_HUMAN,19 (19),0.135,1,, fatty acid β-oxidation,HumanCyc,1,HCD2_HUMAN,19 (19),0.135,1,, Prostacyclin signalling through prostacyclin receptor,Reactome,1,GNAS1_HUMAN,19 (19),0.135,1,, Ephrin signaling,Reactome,1,GIT1_HUMAN,19 (19),0.135,1,, gata3 participate in activating the th2 cytokine genes expression,BioCarta,1,GNAS1_HUMAN,19 (19),0.135,1,, RHO GTPases activate CIT,Reactome,1,MYH9_HUMAN,19 (19),0.135,1,, Other semaphorin interactions,Reactome,1,SEM6D_HUMAN,19 (19),0.135,1,, fatty acid β-oxidation (peroxisome),HumanCyc,1,HCD2_HUMAN,19 (19),0.135,1,, Apoptosis Modulation by HSP70,Wikipathways,1,AIFM1_HUMAN,19 (19),0.135,1,, Mitochondrial Gene Expression,Wikipathways,1,PRGC2_HUMAN,19 (19),0.135,1,, Tight junction - Homo sapiens (human),KEGG,3,2ABB_HUMAN;MYH9_HUMAN;MYH7B_HUMAN,170 (170),0.14,1,, retinol biosynthesis,HumanCyc,1,EST1_HUMAN,20 (20),0.142,1,, Sema4D induced cell migration and growth-cone collapse,Reactome,1,MYH9_HUMAN,20 (20),0.142,1,, 3-phosphoinositide degradation,HumanCyc,1,PI5PA_HUMAN,20 (20),0.142,1,, Globo Sphingolipid Metabolism,Wikipathways,1,SIA7F_HUMAN,20 (20),0.142,1,, Nanomaterial induced apoptosis,Wikipathways,1,AIFM1_HUMAN,20 (20),0.142,1,, Olfactory bulb development and olfactory learning,Wikipathways,1,PCNT_HUMAN,20 (20),0.142,1,, RNA Polymerase II Pre-transcription Events,Reactome,2,CDC73_HUMAN;RPB7_HUMAN,87 (88),0.142,1,, Regulation of PLK1 Activity at G2/M Transition,Reactome,2,PCNT_HUMAN;AKAP9_HUMAN,87 (87),0.142,1,, Gap junction - Homo sapiens (human),KEGG,2,GNAS1_HUMAN;GRM5_HUMAN,88 (88),0.145,1,, Dilated cardiomyopathy (DCM) - Homo sapiens (human),KEGG,2,GNAS1_HUMAN;CACB1_HUMAN,89 (90),0.148,1,, Mitochondrial tRNA aminoacylation,Reactome,1,SYAM_HUMAN,21 (21),0.149,1,, RHO GTPases activate PAKs,Reactome,1,MYH9_HUMAN,21 (21),0.149,1,, Glycosphingolipid biosynthesis - ganglioseries,EHMN,1,COPB2_HUMAN,21 (21),0.149,1,, Mono-unsaturated fatty acid beta-oxidation,EHMN,1,HCD2_HUMAN,21 (21),0.149,1,, Neuronal System,Reactome,5,KCNJ3_HUMAN;GRM5_HUMAN;GRIK4_HUMAN;AKAP9_HUMAN;CACB1_HUMAN,368 (368),0.15,1,, Morphine addiction - Homo sapiens (human),KEGG,2,KCNJ3_HUMAN;GNAS1_HUMAN,91 (91),0.153,1,, mRNA Splicing - Major Pathway,Reactome,3,SNUT2_HUMAN;SRRM2_HUMAN;RPB7_HUMAN,178 (178),0.155,1,, superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis,HumanCyc,1,PYR1_HUMAN,22 (22),0.155,1,, The canonical retinoid cycle in rods (twilight vision),Reactome,1,MYO7A_HUMAN,22 (22),0.155,1,, cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway,BioCarta,1,GNAS1_HUMAN,22 (22),0.155,1,, Common Pathway of Fibrin Clot Formation,Reactome,1,FA5_HUMAN,22 (22),0.155,1,, miRNA targets in ECM and membrane receptors,Wikipathways,1,LAMB2_HUMAN,22 (44),0.155,1,, heparan sulfate biosynthesis (late stages),HumanCyc,1,NDST1_HUMAN,22 (22),0.155,1,, Inositol Metabolism,SMPDB,1,PI5PA_HUMAN,22 (22),0.155,1,, IL-17 signaling pathway - Homo sapiens (human),KEGG,2,UBP25_HUMAN;NGAL_HUMAN,93 (93),0.158,1,, Neuroactive ligand-receptor interaction - Homo sapiens (human),KEGG,4,GIPR_HUMAN;P2Y11_HUMAN;GRM5_HUMAN;GRIK4_HUMAN,277 (277),0.161,1,, Abortive elongation of HIV-1 transcript in the absence of Tat,Reactome,1,RPB7_HUMAN,23 (23),0.162,1,, Estrogen signaling pathway,Wikipathways,1,GNAS1_HUMAN,23 (23),0.162,1,, Branched-chain amino acid catabolism,Reactome,1,HCD2_HUMAN,23 (23),0.162,1,, Laminin interactions,Reactome,1,LAMB2_HUMAN,23 (23),0.162,1,, intrinsic prothrombin activation pathway,BioCarta,1,FA5_HUMAN,23 (23),0.162,1,, how progesterone initiates the oocyte maturation,BioCarta,1,GNAS1_HUMAN,23 (23),0.162,1,, 2-Hydroxyglutric Aciduria (D And L Form),SMPDB,1,PYR1_HUMAN,23 (23),0.162,1,, Pyrimidine Metabolism,SMPDB,1,PYR1_HUMAN,23 (23),0.162,1,, Irinotecan Action Pathway,SMPDB,1,EST1_HUMAN,23 (23),0.162,1,, UMP Synthase Deiciency (Orotic Aciduria),SMPDB,1,PYR1_HUMAN,23 (23),0.162,1,, Homocarnosinosis,SMPDB,1,PYR1_HUMAN,23 (23),0.162,1,, Hyperinsulinism-Hyperammonemia Syndrome,SMPDB,1,PYR1_HUMAN,23 (23),0.162,1,, Succinic semialdehyde dehydrogenase deficiency,SMPDB,1,PYR1_HUMAN,23 (23),0.162,1,, MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),SMPDB,1,PYR1_HUMAN,23 (23),0.162,1,, Irinotecan Metabolism Pathway,SMPDB,1,EST1_HUMAN,23 (23),0.162,1,, 4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency,SMPDB,1,PYR1_HUMAN,23 (23),0.162,1,, Glutamate Metabolism,SMPDB,1,PYR1_HUMAN,23 (23),0.162,1,, Beta Ureidopropionase Deficiency,SMPDB,1,PYR1_HUMAN,23 (23),0.162,1,, Dihydropyrimidinase Deficiency,SMPDB,1,PYR1_HUMAN,23 (23),0.162,1,, Di-unsaturated fatty acid beta-oxidation,EHMN,1,HCD2_HUMAN,23 (23),0.162,1,, GPCRs_ Class B Secretin-like,Wikipathways,1,GIPR_HUMAN,23 (23),0.162,1,, Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling,Wikipathways,1,EST1_HUMAN,23 (23),0.162,1,, Post-translational protein modification,Reactome,14,UBP25_HUMAN;SPTN5_HUMAN;TFG_HUMAN;LAMB2_HUMAN;FA7_HUMAN;COPB2_HUMAN;MFGM_HUMAN;C1GLT_HUMAN;FA5_HUMAN;CDC73_HUMAN;SIA7F_HUMAN;FBX9_HUMAN;OTU7B_HUMAN;RD23B_HUMAN,1377 (1383),0.162,1,, Amoebiasis - Homo sapiens (human),KEGG,2,LAMB2_HUMAN;GNAS1_HUMAN,95 (96),0.164,1,, Class B/2 (Secretin family receptors),Reactome,2,GIPR_HUMAN;GNAS1_HUMAN,95 (96),0.164,1,, Glycosaminoglycan biosynthesis - heparan sulfate / heparin - Homo sapiens (human),KEGG,1,NDST1_HUMAN,24 (24),0.168,1,, Vitamin digestion and absorption - Homo sapiens (human),KEGG,1,CUBN_HUMAN,24 (24),0.168,1,, regulation of ck1/cdk5 by type 1 glutamate receptors,BioCarta,1,GNAS1_HUMAN,24 (24),0.168,1,, Sema4D in semaphorin signaling,Reactome,1,MYH9_HUMAN,24 (24),0.168,1,, Fluoropyrimidine Pathway_ Pharmacokinetics,PharmGKB,1,EST1_HUMAN,24 (24),0.168,1,, Transcriptional activation of mitochondrial biogenesis,Reactome,1,PRGC2_HUMAN,24 (27),0.168,1,, Miscellaneous transport and binding events,Reactome,1,ADDA_HUMAN,24 (24),0.168,1,, Triacylglyceride Synthesis,Wikipathways,1,ADAS_HUMAN,24 (24),0.168,1,, Anchoring of the basal body to the plasma membrane,Reactome,2,PCNT_HUMAN;AKAP9_HUMAN,97 (97),0.169,1,, Interleukin-4 and Interleukin-13 signaling,Wikipathways,2,PO2F1_HUMAN;NGAL_HUMAN,97 (97),0.169,1,, Mitotic Prometaphase,Reactome,3,PCNT_HUMAN;AKAP9_HUMAN;PDS5B_HUMAN,186 (186),0.169,1,, mRNA Splicing,Reactome,3,SNUT2_HUMAN;SRRM2_HUMAN;RPB7_HUMAN,186 (186),0.169,1,, Activation of G protein gated Potassium channels,Reactome,1,KCNJ3_HUMAN,25 (25),0.174,1,, TRP channels,Reactome,1,TRPA1_HUMAN,25 (25),0.174,1,, Alanine Aspartate Asparagine metabolism,INOH,1,PYR1_HUMAN,25 (25),0.174,1,, EGFR downregulation,Reactome,1,EP15R_HUMAN,25 (25),0.174,1,, Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits,Reactome,1,KCNJ3_HUMAN,25 (25),0.174,1,, Saturated fatty acids beta-oxidation,EHMN,1,HCD2_HUMAN,25 (25),0.174,1,, G protein gated Potassium channels,Reactome,1,KCNJ3_HUMAN,25 (25),0.174,1,, Differentiation of white and brown adipocyte,Wikipathways,1,PRGC2_HUMAN,25 (25),0.174,1,, Phosphatidylinositol signaling system - Homo sapiens (human),KEGG,2,IMPA3_HUMAN;PI5PA_HUMAN,99 (99),0.175,1,, Cargo recognition for clathrin-mediated endocytosis,Reactome,2,NECP1_HUMAN;EP15R_HUMAN,99 (99),0.175,1,, Pyrimidine metabolism - Homo sapiens (human),KEGG,2,RPB7_HUMAN;PYR1_HUMAN,101 (101),0.18,1,, L1CAM interactions,Reactome,2,SCN5A_HUMAN;SPTN5_HUMAN,101 (103),0.18,1,, Cytosolic sulfonation of small molecules,Reactome,1,IMPA3_HUMAN,26 (26),0.181,1,, TSH,NetPath,1,GNAS1_HUMAN,26 (26),0.181,1,, signaling pathway from g-protein families,BioCarta,1,GNAS1_HUMAN,26 (26),0.181,1,, Glutamate Glutamine metabolism,INOH,1,PYR1_HUMAN,26 (27),0.181,1,, TNFR1-induced NFkappaB signaling pathway,Reactome,1,OTU7B_HUMAN,26 (26),0.181,1,, Vitamin B9 (folate) metabolism,EHMN,1,COPB2_HUMAN,26 (26),0.181,1,, Huntington disease - Homo sapiens (human),KEGG,3,GRM5_HUMAN;RPB7_HUMAN;DYH11_HUMAN,193 (193),0.183,1,, Stimuli-sensing channels,Reactome,2,ASIC5_HUMAN;TRPA1_HUMAN,102 (102),0.183,1,, Chagas disease (American trypanosomiasis) - Homo sapiens (human),KEGG,2,2ABB_HUMAN;GNAS1_HUMAN,102 (102),0.183,1,, FGFR2 alternative splicing,Reactome,1,RPB7_HUMAN,27 (27),0.187,1,, RNA Pol II CTD phosphorylation and interaction with CE during HIV infection,Reactome,1,RPB7_HUMAN,27 (27),0.187,1,, RNA Pol II CTD phosphorylation and interaction with CE,Reactome,1,RPB7_HUMAN,27 (27),0.187,1,, corticosteroids and cardioprotection,BioCarta,1,GNAS1_HUMAN,27 (27),0.187,1,, transcription factor creb and its extracellular signals,BioCarta,1,GNAS1_HUMAN,27 (27),0.187,1,, Synthesis of IP3 and IP4 in the cytosol,Reactome,1,PI5PA_HUMAN,27 (27),0.187,1,, CREB phosphorylation through the activation of Ras,Reactome,1,AKAP9_HUMAN,27 (27),0.187,1,, MET promotes cell motility,Reactome,1,LAMB2_HUMAN,27 (27),0.187,1,, GPCR GroupI metabotropic glutamate receptor,INOH,1,GRM5_HUMAN,28 (28),0.193,1,, Selective Serotonin Reuptake Inhibitor Pathway_ Pharmacodynamics,PharmGKB,1,GNAS1_HUMAN,28 (28),0.193,1,, Omega-6 fatty acid metabolism,EHMN,1,HCD2_HUMAN,28 (28),0.193,1,, Regulation of RUNX2 expression and activity,Reactome,1,PRGC2_HUMAN,28 (28),0.193,1,, Calcium signaling in the CD4+ TCR pathway,PID,1,PO2F1_HUMAN,29 (29),0.199,1,, heparan sulfate biosynthesis,HumanCyc,1,NDST1_HUMAN,29 (29),0.199,1,, mRNA Capping,Reactome,1,RPB7_HUMAN,29 (29),0.199,1,, Diuretics Pathway_ Pharmacodynamics,PharmGKB,1,ADDA_HUMAN,29 (29),0.199,1,, Levomethadyl Acetate Action Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Escitalopram Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Levallorphan Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Dimethylthiambutene Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Ethylmorphine Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Pentazocine Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Naltrexone Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Buprenorphine Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Alvimopan Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Naloxone Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Dihydromorphine Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Ketobemidone Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Mepivacaine Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Chloroprocaine Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Cocaine Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Dibucaine Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Levobupivacaine Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Benzocaine Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Bupivacaine Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Levorphanol Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Propoxyphene Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Tramadol Action Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Diphenoxylate Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Anileridine Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Oxycodone Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Oxybuprocaine Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Prilocaine Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Procaine Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Proparacaine Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Ropivacaine Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Alfentanil Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Oxymorphone Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Hydrocodone Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Hydromorphone Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Sufentanil Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Remifentanil Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Fentanyl Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Carfentanil Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, 3-Methylthiofentanyl Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Methadyl Acetate Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, Dezocine Action Pathway,SMPDB,1,CACB1_HUMAN,29 (29),0.199,1,, RNA Polymerase III Transcription Initiation From Type 3 Promoter,Reactome,1,PO2F1_HUMAN,29 (29),0.199,1,, Tyrosine metabolism,EHMN,2,HCD2_HUMAN;COPB2_HUMAN,110 (110),0.205,1,, Activation of kainate receptors upon glutamate binding,Reactome,1,GRIK4_HUMAN,30 (30),0.205,1,, #NAME?,BioCarta,1,GNAS1_HUMAN,30 (30),0.205,1,, mucin core 1 and core 2 O-glycosylation,HumanCyc,1,C1GLT_HUMAN,30 (30),0.205,1,, Desipramine Action Pathway,SMPDB,1,CACB1_HUMAN,30 (30),0.205,1,, 3-Methylglutaconic Aciduria Type I,SMPDB,1,HCD2_HUMAN,30 (30),0.205,1,, Valine_ Leucine and Isoleucine Degradation,SMPDB,1,HCD2_HUMAN,30 (30),0.205,1,, 2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency,SMPDB,1,HCD2_HUMAN,30 (30),0.205,1,, Nalbuphine Action Pathway,SMPDB,1,CACB1_HUMAN,30 (30),0.205,1,, Isovaleric Aciduria,SMPDB,1,HCD2_HUMAN,30 (30),0.205,1,, 3-Methylcrotonyl Coa Carboxylase Deficiency Type I,SMPDB,1,HCD2_HUMAN,30 (30),0.205,1,, Propionic Acidemia,SMPDB,1,HCD2_HUMAN,30 (30),0.205,1,, Maple Syrup Urine Disease,SMPDB,1,HCD2_HUMAN,30 (30),0.205,1,, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency,SMPDB,1,HCD2_HUMAN,30 (30),0.205,1,, Isobutyryl-coa dehydrogenase deficiency,SMPDB,1,HCD2_HUMAN,30 (30),0.205,1,, 3-hydroxyisobutyric aciduria,SMPDB,1,HCD2_HUMAN,30 (30),0.205,1,, 3-hydroxyisobutyric acid dehydrogenase deficiency,SMPDB,1,HCD2_HUMAN,30 (30),0.205,1,, Isovaleric acidemia,SMPDB,1,HCD2_HUMAN,30 (30),0.205,1,, Methylmalonate Semialdehyde Dehydrogenase Deficiency,SMPDB,1,HCD2_HUMAN,30 (30),0.205,1,, Methylmalonic Aciduria,SMPDB,1,HCD2_HUMAN,30 (30),0.205,1,, 3-Methylglutaconic Aciduria Type IV,SMPDB,1,HCD2_HUMAN,30 (30),0.205,1,, 3-Methylglutaconic Aciduria Type III,SMPDB,1,HCD2_HUMAN,30 (30),0.205,1,, Beta-Ketothiolase Deficiency,SMPDB,1,HCD2_HUMAN,30 (30),0.205,1,, Proteoglycan biosynthesis,EHMN,1,COPB2_HUMAN,30 (30),0.205,1,, Extracellular vesicle-mediated signaling in recipient cells,Wikipathways,1,MFGM_HUMAN,30 (30),0.205,1,, Nucleotide Excision Repair,Reactome,2,RPB7_HUMAN;RD23B_HUMAN,112 (113),0.21,1,, Mucin type O-glycan biosynthesis - Homo sapiens (human),KEGG,1,C1GLT_HUMAN,31 (31),0.212,1,, HS-GAG biosynthesis,Reactome,1,NDST1_HUMAN,31 (31),0.212,1,, Aurora A signaling,PID,1,GIT1_HUMAN,31 (31),0.212,1,, Circadian rhythm - Homo sapiens (human),KEGG,1,PER3_HUMAN,31 (31),0.212,1,, RNA polymerase - Homo sapiens (human),KEGG,1,RPB7_HUMAN,31 (31),0.212,1,, activation of camp-dependent protein kinase pka,BioCarta,1,GNAS1_HUMAN,31 (31),0.212,1,, Lidocaine (Local Anaesthetic) Action Pathway,SMPDB,1,CACB1_HUMAN,31 (31),0.212,1,, Ethanol effects on histone modifications,Wikipathways,1,HDAC9_HUMAN,31 (31),0.212,1,, Inwardly rectifying K+ channels,Reactome,1,KCNJ3_HUMAN,31 (31),0.212,1,, Alpha-synuclein signaling,PID,1,SNCAP_HUMAN,32 (32),0.218,1,, rho cell motility signaling pathway,BioCarta,1,COF1_HUMAN,32 (34),0.218,1,, role of -arrestins in the activation and targeting of map kinases,BioCarta,1,GNAS1_HUMAN,32 (32),0.218,1,, Valine Leucine Isoleucine degradation,INOH,1,HCD2_HUMAN,32 (32),0.218,1,, Translocation of GLUT4 to the plasma membrane,Reactome,1,MYO1C_HUMAN,32 (32),0.218,1,, Codeine Action Pathway,SMPDB,1,CACB1_HUMAN,32 (32),0.218,1,, Initiation of transcription and translation elongation at the HIV-1 LTR,Wikipathways,1,HDAC9_HUMAN,32 (32),0.218,1,, Serotonergic synapse - Homo sapiens (human),KEGG,2,KCNJ3_HUMAN;GNAS1_HUMAN,115 (115),0.219,1,, Golgi-to-ER retrograde transport,Reactome,2,KIF11_HUMAN;COPB2_HUMAN,116 (116),0.222,1,, Regulation of actin cytoskeleton - Homo sapiens (human),KEGG,3,COF1_HUMAN;MYH9_HUMAN;GIT1_HUMAN,213 (213),0.222,1,, Inflammatory Response Pathway,Wikipathways,1,LAMB2_HUMAN,33 (33),0.224,1,, Formation of the HIV-1 Early Elongation Complex,Reactome,1,RPB7_HUMAN,33 (33),0.224,1,, Glucagon signaling in metabolic regulation,Reactome,1,GNAS1_HUMAN,33 (33),0.224,1,, Formation of the Early Elongation Complex,Reactome,1,RPB7_HUMAN,33 (33),0.224,1,, Plasma lipoprotein clearance,Reactome,1,CUBN_HUMAN,33 (33),0.224,1,, ceramide signaling pathway,BioCarta,1,AIFM1_HUMAN,33 (33),0.224,1,, Cargo concentration in the ER,Reactome,1,FA5_HUMAN,33 (33),0.224,1,, Sialic acid metabolism,Reactome,1,SIA7F_HUMAN,33 (33),0.224,1,, Imipramine Action Pathway,SMPDB,1,CACB1_HUMAN,33 (33),0.224,1,, Fluoropyrimidine Activity,Wikipathways,1,EST1_HUMAN,33 (34),0.224,1,, Alpha 6 Beta 4 signaling pathway,Wikipathways,1,LAMB2_HUMAN,33 (33),0.224,1,, N-glycan trimming in the ER and Calnexin/Calreticulin cycle,Reactome,1,RD23B_HUMAN,34 (34),0.229,1,, Alpha4 beta1 integrin signaling events,PID,1,GIT1_HUMAN,34 (34),0.229,1,, Fluoxetine Action Pathway,SMPDB,1,CACB1_HUMAN,34 (34),0.229,1,, Prostaglandin formation from arachidonate,EHMN,1,COPB2_HUMAN,34 (34),0.229,1,, Melatonin metabolism and effects,Wikipathways,1,PER3_HUMAN,34 (34),0.229,1,, Smooth Muscle Contraction,Reactome,1,ANXA6_HUMAN,35 (35),0.235,1,, Circadian Clock,Reactome,1,FA7_HUMAN,35 (35),0.235,1,, Transcriptional Regulation by E2F6,Reactome,1,MGAP_HUMAN,35 (35),0.235,1,, Alanine_ aspartate and glutamate metabolism - Homo sapiens (human),KEGG,1,PYR1_HUMAN,35 (35),0.235,1,, Arf6 signaling events,PID,1,GIT1_HUMAN,35 (35),0.235,1,, EPHB-mediated forward signaling,Reactome,1,COF1_HUMAN,35 (35),0.235,1,, Glucagon-like Peptide-1 (GLP1) regulates insulin secretion,Reactome,1,GNAS1_HUMAN,35 (35),0.235,1,, Post NMDA receptor activation events,Reactome,1,AKAP9_HUMAN,35 (35),0.235,1,, Amyotrophic lateral sclerosis (ALS),Wikipathways,1,NFM_HUMAN,35 (35),0.235,1,, miRNAs involvement in the immune response in sepsis,Wikipathways,1,NGAL_HUMAN,36 (64),0.241,1,, Glycogen Synthesis and Degradation,Wikipathways,1,2ABB_HUMAN,36 (36),0.241,1,, roles of arrestin dependent recruitment of src kinases in gpcr signaling,BioCarta,1,GNAS1_HUMAN,36 (36),0.241,1,, rac1 cell motility signaling pathway,BioCarta,1,COF1_HUMAN,36 (38),0.241,1,, GPCR Adenosine A2A receptor,INOH,1,GNAS1_HUMAN,36 (36),0.241,1,, Citalopram Action Pathway,SMPDB,1,CACB1_HUMAN,36 (36),0.241,1,, Nicotine Action Pathway,SMPDB,1,CACB1_HUMAN,36 (36),0.241,1,, Methadone Action Pathway,SMPDB,1,CACB1_HUMAN,36 (36),0.241,1,, CRH,NetPath,1,GNAS1_HUMAN,36 (36),0.241,1,, Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,Wikipathways,1,COF1_HUMAN,36 (36),0.241,1,, Integrin,INOH,2,DOC10_HUMAN;DOCK9_HUMAN,124 (124),0.244,1,, NCAM1 interactions,Reactome,1,CACB1_HUMAN,37 (37),0.247,1,, Tat-mediated HIV elongation arrest and recovery,Reactome,1,RPB7_HUMAN,37 (38),0.247,1,, Pausing and recovery of Tat-mediated HIV elongation,Reactome,1,RPB7_HUMAN,37 (38),0.247,1,, ATR signaling pathway,PID,1,2ABB_HUMAN,37 (37),0.247,1,, RHO GTPases Activate WASPs and WAVEs,Reactome,1,SPN90_HUMAN,37 (37),0.247,1,, Thyroid cancer - Homo sapiens (human),KEGG,1,TFG_HUMAN,37 (37),0.247,1,, TNF signaling,Reactome,1,OTU7B_HUMAN,37 (37),0.247,1,, O-Glycan biosynthesis,EHMN,1,COPB2_HUMAN,37 (37),0.247,1,, RNA Polymerase III Transcription Initiation,Reactome,1,PO2F1_HUMAN,37 (37),0.247,1,, Metabolism of proteins,Reactome,18,UBP25_HUMAN;SPTN5_HUMAN;TFG_HUMAN;SYAM_HUMAN;LAMB2_HUMAN;SIA7F_HUMAN;FA7_HUMAN;COPB2_HUMAN;MFGM_HUMAN;RM44_HUMAN;C1GLT_HUMAN;FA5_HUMAN;ADAS_HUMAN;CDC73_HUMAN;SNCAP_HUMAN;FBX9_HUMAN;OTU7B_HUMAN;RD23B_HUMAN,1991 (2008),0.252,1,, G13 Signaling Pathway,Wikipathways,1,COF1_HUMAN,38 (38),0.253,1,, Signaling events mediated by HDAC Class II,PID,1,HDAC9_HUMAN,38 (38),0.253,1,, Apoptotic cleavage of cellular proteins,Reactome,1,ADDA_HUMAN,38 (38),0.253,1,, Hedgehog _on_ state,Reactome,1,CDC73_HUMAN,38 (39),0.253,1,, Ovarian tumor domain proteases,Reactome,1,OTU7B_HUMAN,38 (38),0.253,1,, tRNA charging,HumanCyc,1,SYAM_HUMAN,38 (38),0.253,1,, Intracellular Signalling Through Adenosine Receptor A2b and Adenosine,SMPDB,1,GNAS1_HUMAN,38 (38),0.253,1,, Intracellular Signalling Through Adenosine Receptor A2a and Adenosine,SMPDB,1,GNAS1_HUMAN,38 (38),0.253,1,, DNA Damage Recognition in GG-NER,Reactome,1,RD23B_HUMAN,38 (38),0.253,1,, Parkinsons Disease Pathway,Wikipathways,1,SNCAP_HUMAN,38 (71),0.253,1,, M Phase,Reactome,4,PCNT_HUMAN;NIPBL_HUMAN;AKAP9_HUMAN;PDS5B_HUMAN,338 (340),0.258,1,, HIV elongation arrest and recovery,Reactome,1,RPB7_HUMAN,39 (40),0.259,1,, Pausing and recovery of HIV elongation,Reactome,1,RPB7_HUMAN,39 (40),0.259,1,, Gamma carboxylation_ hypusine formation and arylsulfatase activation,Reactome,1,FA7_HUMAN,39 (40),0.259,1,, Activation of GABAB receptors,Reactome,1,KCNJ3_HUMAN,39 (39),0.259,1,, GABA B receptor activation,Reactome,1,KCNJ3_HUMAN,39 (39),0.259,1,, Activation of NMDA receptor and postsynaptic events,Reactome,1,AKAP9_HUMAN,39 (39),0.259,1,, Fanconi Anemia Pathway,Reactome,1,DCR1B_HUMAN,40 (41),0.264,1,, Class C/3 (Metabotropic glutamate/pheromone receptors),Reactome,1,GRM5_HUMAN,40 (40),0.264,1,, Vasopressin regulates renal water homeostasis via Aquaporins,Reactome,1,GNAS1_HUMAN,40 (40),0.264,1,, Hematopoietic Stem Cell Differentiation,Wikipathways,1,TRI29_HUMAN,40 (49),0.264,1,, VEGFA-VEGFR2 Signaling Pathway,Wikipathways,3,COF1_HUMAN;MYH9_HUMAN;HDAC9_HUMAN,236 (236),0.269,1,, Spliceosome - Homo sapiens (human),KEGG,2,SLU7_HUMAN;SNUT2_HUMAN,133 (134),0.27,1,, Eukaryotic Transcription Initiation,Wikipathways,1,RPB7_HUMAN,41 (41),0.27,1,, Organelle biogenesis and maintenance,Reactome,3,PRGC2_HUMAN;PCNT_HUMAN;AKAP9_HUMAN,237 (240),0.271,1,, Gene Silencing by RNA,Reactome,2,RPB7_HUMAN;DGCR8_HUMAN,134 (134),0.272,1,, Viral Messenger RNA Synthesis,Reactome,1,RPB7_HUMAN,42 (42),0.275,1,, Stabilization and expansion of the E-cadherin adherens junction,PID,1,GIT1_HUMAN,42 (42),0.275,1,, Plasma membrane estrogen receptor signaling,PID,1,GNAS1_HUMAN,42 (42),0.275,1,, chrebp regulation by carbohydrates and camp,BioCarta,1,GNAS1_HUMAN,42 (42),0.275,1,, Non-integrin membrane-ECM interactions,Reactome,1,LAMB2_HUMAN,42 (42),0.275,1,, tRNA Aminoacylation,Reactome,1,SYAM_HUMAN,42 (42),0.275,1,, N-Glycan biosynthesis,EHMN,1,COPB2_HUMAN,42 (42),0.275,1,, RNA Polymerase III Abortive And Retractive Initiation,Reactome,1,PO2F1_HUMAN,42 (42),0.275,1,, RNA Polymerase III Transcription,Reactome,1,PO2F1_HUMAN,42 (42),0.275,1,, Regulation of actin dynamics for phagocytic cup formation,Reactome,2,COF1_HUMAN;SPN90_HUMAN,136 (141),0.278,1,, Glycerophospholipid metabolism,EHMN,2,ADAS_HUMAN;COPB2_HUMAN,136 (136),0.278,1,, Pyrimidine metabolism,EHMN,2,RPB7_HUMAN;COPB2_HUMAN,136 (136),0.278,1,, Estrogen signaling pathway - Homo sapiens (human),KEGG,2,KCNJ3_HUMAN;GNAS1_HUMAN,137 (137),0.281,1,, G2/M Transition,Reactome,2,PCNT_HUMAN;AKAP9_HUMAN,137 (137),0.281,1,, Kinesins,Reactome,1,KIF11_HUMAN,43 (43),0.281,1,, LKB1 signaling events,PID,1,BRSK1_HUMAN,43 (43),0.281,1,, activation of csk by camp-dependent protein kinase inhibits signaling through the t cell receptor,BioCarta,1,GNAS1_HUMAN,43 (45),0.281,1,, Signaling by EGFR,Reactome,1,EP15R_HUMAN,43 (43),0.281,1,, Hedgehog _off_ state,Reactome,1,GNAS1_HUMAN,43 (44),0.281,1,, Formation of Incision Complex in GG-NER,Reactome,1,RD23B_HUMAN,43 (43),0.281,1,, Vitamin E metabolism,EHMN,1,HCD2_HUMAN,43 (43),0.281,1,, Steroid hormones,Reactome,1,CUBN_HUMAN,43 (43),0.281,1,, Clathrin-mediated endocytosis,Reactome,2,NECP1_HUMAN;EP15R_HUMAN,138 (138),0.284,1,, nfat and hypertrophy of the heart ,BioCarta,1,HDAC9_HUMAN,44 (44),0.286,1,, Influenza Viral RNA Transcription and Replication,Reactome,1,RPB7_HUMAN,44 (44),0.286,1,, FOXA1 transcription factor network,PID,1,PO2F1_HUMAN,44 (44),0.286,1,, Aminoacyl-tRNA biosynthesis - Homo sapiens (human),KEGG,1,SYAM_HUMAN,44 (66),0.286,1,, Vasopressin-regulated water reabsorption - Homo sapiens (human),KEGG,1,GNAS1_HUMAN,44 (44),0.286,1,, Morphine Action Pathway,SMPDB,1,CACB1_HUMAN,44 (44),0.286,1,, Galactose metabolism,EHMN,1,COPB2_HUMAN,44 (44),0.286,1,, Mitotic G2-G2/M phases,Reactome,2,PCNT_HUMAN;AKAP9_HUMAN,139 (139),0.287,1,, a6b1 and a6b4 Integrin signaling,PID,1,LAMB2_HUMAN,45 (45),0.292,1,, RhoA signaling pathway,PID,1,COF1_HUMAN,45 (45),0.292,1,, RAGE,NetPath,1,AIFM1_HUMAN,45 (45),0.292,1,, Estrogen-dependent gene expression,Reactome,2,PO2F1_HUMAN;RPB7_HUMAN,141 (142),0.292,1,, Parkinson disease - Homo sapiens (human),KEGG,2,NU4M_HUMAN;SNCAP_HUMAN,142 (142),0.295,1,, Tryptophan metabolism,Wikipathways,1,HCD2_HUMAN,46 (46),0.297,1,, RNA Polymerase II Promoter Escape,Reactome,1,RPB7_HUMAN,46 (46),0.297,1,, Proton Pump Inhibitor Pathway_ Pharmacodynamics,PharmGKB,1,GNAS1_HUMAN,46 (46),0.297,1,, RNA Polymerase II HIV Promoter Escape,Reactome,1,RPB7_HUMAN,47 (47),0.303,1,, RNA Polymerase II Transcription Initiation,Reactome,1,RPB7_HUMAN,47 (47),0.303,1,, RNA Polymerase II Transcription Initiation And Promoter Clearance,Reactome,1,RPB7_HUMAN,47 (47),0.303,1,, Energy Metabolism,Wikipathways,1,PRGC2_HUMAN,47 (47),0.303,1,, Nucleotide excision repair - Homo sapiens (human),KEGG,1,RD23B_HUMAN,47 (47),0.303,1,, Endocrine and other factor-regulated calcium reabsorption - Homo sapiens (human),KEGG,1,GNAS1_HUMAN,47 (47),0.303,1,, RNA Polymerase II Transcription Pre-Initiation And Promoter Opening,Reactome,1,RPB7_HUMAN,47 (47),0.303,1,, ion channels and their functional role in vascular endothelium,BioCarta,1,GNAS1_HUMAN,47 (47),0.303,1,, Ether lipid metabolism - Homo sapiens (human),KEGG,1,ADAS_HUMAN,47 (47),0.303,1,, G alpha (z) signalling events,Reactome,1,GNAS1_HUMAN,47 (47),0.303,1,, NOTCH1 Intracellular Domain Regulates Transcription,Reactome,1,HDAC9_HUMAN,47 (47),0.303,1,, XBP1(S) activates chaperone genes,Wikipathways,1,ADDA_HUMAN,47 (47),0.303,1,, NO-cGMP-PKG mediated Neuroprotection,Wikipathways,1,AKAP9_HUMAN,47 (47),0.303,1,, HIV Transcription Initiation,Reactome,1,RPB7_HUMAN,47 (47),0.303,1,, Phospholipase D signaling pathway - Homo sapiens (human),KEGG,2,GNAS1_HUMAN;GRM5_HUMAN,145 (146),0.304,1,, Mesodermal Commitment Pathway,Wikipathways,2,GRHL2_HUMAN;MACF1_HUMAN,146 (153),0.306,1,, Ceramide signaling pathway,PID,1,AIFM1_HUMAN,48 (48),0.308,1,, Valine_ leucine and isoleucine degradation - Homo sapiens (human),KEGG,1,HCD2_HUMAN,48 (48),0.308,1,, agrin in postsynaptic differentiation,BioCarta,1,LAMB2_HUMAN,48 (48),0.308,1,, Formation of HIV-1 elongation complex containing HIV-1 Tat,Reactome,1,RPB7_HUMAN,49 (50),0.313,1,, Tat-mediated elongation of the HIV-1 transcript,Reactome,1,RPB7_HUMAN,49 (50),0.313,1,, HIV Transcription Elongation,Reactome,1,RPB7_HUMAN,49 (50),0.313,1,, Calcineurin-regulated NFAT-dependent transcription in lymphocytes,PID,1,PO2F1_HUMAN,49 (49),0.313,1,, Ovarian steroidogenesis - Homo sapiens (human),KEGG,1,GNAS1_HUMAN,49 (49),0.313,1,, Cocaine addiction - Homo sapiens (human),KEGG,1,GNAS1_HUMAN,49 (49),0.313,1,, Inositol phosphate metabolism,Reactome,1,PI5PA_HUMAN,49 (50),0.313,1,, Platelet Aggregation Inhibitor Pathway_ Pharmacodynamics,PharmGKB,1,GNAS1_HUMAN,49 (49),0.313,1,, Aquaporin-mediated transport,Reactome,1,GNAS1_HUMAN,49 (49),0.313,1,, Valine_ leucine and isoleucine degradation,EHMN,1,HCD2_HUMAN,49 (49),0.313,1,, Regulation of Actin Cytoskeleton,Wikipathways,2,COF1_HUMAN;GIT1_HUMAN,149 (151),0.315,1,, ESR-mediated signaling,Reactome,2,PO2F1_HUMAN;RPB7_HUMAN,149 (150),0.315,1,, Platelet activation_ signaling and aggregation,Reactome,3,COF1_HUMAN;FA5_HUMAN;AACT_HUMAN,259 (260),0.317,1,, Vibrio cholerae infection - Homo sapiens (human),KEGG,1,GNAS1_HUMAN,50 (50),0.319,1,, Mitochondrial biogenesis,Reactome,1,PRGC2_HUMAN,50 (53),0.319,1,, Formation of HIV elongation complex in the absence of HIV Tat,Reactome,1,RPB7_HUMAN,51 (52),0.324,1,, Regulation of Androgen receptor activity,PID,1,PO2F1_HUMAN,51 (51),0.324,1,, Amyotrophic lateral sclerosis (ALS) - Homo sapiens (human),KEGG,1,NFM_HUMAN,51 (51),0.324,1,, Aminosugars metabolism,EHMN,1,COPB2_HUMAN,51 (51),0.324,1,, Pyrimidine nucleotides nucleosides metabolism,INOH,1,PYR1_HUMAN,51 (51),0.324,1,, Fcgamma receptor (FCGR) dependent phagocytosis,Reactome,2,COF1_HUMAN;SPN90_HUMAN,154 (159),0.329,1,, Apoptotic execution phase,Reactome,1,ADDA_HUMAN,52 (52),0.329,1,, mRNA Splicing - Minor Pathway,Reactome,1,RPB7_HUMAN,52 (52),0.329,1,, Hepatitis C - Homo sapiens (human),KEGG,2,2ABB_HUMAN;E2AK4_HUMAN,155 (155),0.332,1,, Influenza Life Cycle,Reactome,1,RPB7_HUMAN,53 (53),0.334,1,, Synthesis of PIPs at the plasma membrane,Reactome,1,PI5PA_HUMAN,53 (53),0.334,1,, Cardiac Progenitor Differentiation,Wikipathways,1,SCN5A_HUMAN,53 (53),0.334,1,, Heparan sulfate/heparin (HS-GAG) metabolism,Reactome,1,NDST1_HUMAN,54 (54),0.339,1,, RAC1 signaling pathway,PID,1,COF1_HUMAN,54 (54),0.339,1,, Validated transcriptional targets of TAp63 isoforms,PID,1,MFGM_HUMAN,54 (55),0.339,1,, Regulation of lipolysis in adipocytes - Homo sapiens (human),KEGG,1,GNAS1_HUMAN,54 (54),0.339,1,, Constitutive Signaling by NOTCH1 PEST Domain Mutants,Reactome,1,HDAC9_HUMAN,54 (54),0.339,1,, Signaling by NOTCH1 PEST Domain Mutants in Cancer,Reactome,1,HDAC9_HUMAN,54 (54),0.339,1,, Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,Reactome,1,HDAC9_HUMAN,54 (54),0.339,1,, Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,Reactome,1,HDAC9_HUMAN,54 (54),0.339,1,, Signaling by NOTCH1 in Cancer,Reactome,1,HDAC9_HUMAN,54 (54),0.339,1,, Cardiac Hypertrophic Response,Wikipathways,1,HDAC9_HUMAN,54 (54),0.339,1,, Complex I biogenesis,Reactome,1,NU4M_HUMAN,55 (55),0.344,1,, GABA receptor activation,Reactome,1,KCNJ3_HUMAN,55 (55),0.344,1,, Golgi Associated Vesicle Biogenesis,Reactome,1,NECP1_HUMAN,56 (56),0.349,1,, ECM proteoglycans,Reactome,1,LAMB2_HUMAN,56 (57),0.349,1,, Formation of TC-NER Pre-Incision Complex,Reactome,1,RPB7_HUMAN,56 (57),0.349,1,, EGF-EGFR Signaling Pathway,Wikipathways,2,COF1_HUMAN;EP15R_HUMAN,162 (162),0.351,1,, Neurexins and neuroligins,Reactome,1,GRM5_HUMAN,57 (57),0.354,1,, Viral myocarditis - Homo sapiens (human),KEGG,1,ABL2_HUMAN,58 (59),0.359,1,, Iron uptake and transport,Reactome,1,NGAL_HUMAN,58 (58),0.359,1,, Celecoxib Pathway_ Pharmacodynamics,PharmGKB,1,CACB1_HUMAN,58 (58),0.359,1,, Signaling by BRAF and RAF fusions,Reactome,1,AKAP9_HUMAN,58 (58),0.359,1,, mRNA 3_-end processing,Reactome,1,SLU7_HUMAN,58 (58),0.359,1,, Protein processing in endoplasmic reticulum - Homo sapiens (human),KEGG,2,E2AK4_HUMAN;RD23B_HUMAN,165 (165),0.359,1,, E3 ubiquitin ligases ubiquitinate target proteins,Reactome,1,CDC73_HUMAN,59 (59),0.364,1,, Lysine metabolism,EHMN,1,NSD1_HUMAN,59 (60),0.364,1,, C21-steroid hormone biosynthesis and metabolism,EHMN,1,COPB2_HUMAN,59 (59),0.364,1,, Lysine degradation - Homo sapiens (human),KEGG,1,NSD1_HUMAN,59 (59),0.364,1,, Oxidative phosphorylation,Wikipathways,1,NU4M_HUMAN,60 (61),0.369,1,, ATF-2 transcription factor network,PID,1,PO2F1_HUMAN,60 (60),0.369,1,, Long-term depression - Homo sapiens (human),KEGG,1,GNAS1_HUMAN,60 (60),0.369,1,, RIG-I-like Receptor Signaling,Wikipathways,1,AZI2_HUMAN,60 (60),0.369,1,, Signaling by MET,Reactome,1,LAMB2_HUMAN,61 (61),0.374,1,, Oncogenic MAPK signaling,Reactome,1,AKAP9_HUMAN,61 (61),0.374,1,, Leptin,NetPath,1,SOCS7_HUMAN,62 (62),0.379,1,, Influenza Infection,Reactome,1,RPB7_HUMAN,63 (63),0.383,1,, Integrins in angiogenesis,PID,1,MFGM_HUMAN,63 (63),0.383,1,, Synthesis of substrates in N-glycan biosythesis,Reactome,1,SIA7F_HUMAN,63 (63),0.383,1,, Endothelins,PID,1,GNAS1_HUMAN,64 (64),0.388,1,, Peroxisomal protein import,Reactome,1,ADAS_HUMAN,64 (64),0.388,1,, Cortisol synthesis and secretion - Homo sapiens (human),KEGG,1,GNAS1_HUMAN,64 (64),0.388,1,, Association Between Physico-Chemical Features and Toxicity Associated Pathways,Wikipathways,1,NFM_HUMAN,64 (65),0.388,1,, Renin secretion - Homo sapiens (human),KEGG,1,GNAS1_HUMAN,65 (65),0.393,1,, Deubiquitination,Reactome,3,UBP25_HUMAN;OTU7B_HUMAN;RD23B_HUMAN,296 (296),0.394,1,, Beta1 integrin cell surface interactions,PID,1,LAMB2_HUMAN,66 (66),0.398,1,, Signaling by ROBO receptors,Reactome,1,ABL2_HUMAN,66 (66),0.398,1,, Human Thyroid Stimulating Hormone (TSH) signaling pathway,Wikipathways,1,GNAS1_HUMAN,66 (66),0.398,1,, Histone Modifications,Wikipathways,1,NSD1_HUMAN,66 (66),0.398,1,, Ion channel transport,Reactome,2,ASIC5_HUMAN;TRPA1_HUMAN,179 (179),0.398,1,, Alcoholism - Homo sapiens (human),KEGG,2,GNAS1_HUMAN;HDAC9_HUMAN,180 (180),0.4,1,, Cleavage of Growing Transcript in the Termination Region ,Reactome,1,SLU7_HUMAN,67 (67),0.402,1,, RNA Polymerase II Transcription Termination,Reactome,1,SLU7_HUMAN,67 (67),0.402,1,, Long-term potentiation - Homo sapiens (human),KEGG,1,GRM5_HUMAN,67 (67),0.402,1,, O-linked glycosylation of mucins,Reactome,1,C1GLT_HUMAN,67 (67),0.402,1,, Gap-filling DNA repair synthesis and ligation in TC-NER,Reactome,1,RPB7_HUMAN,67 (68),0.402,1,, RHO GTPase Effectors,Reactome,3,COF1_HUMAN;MYH9_HUMAN;SPN90_HUMAN,301 (301),0.404,1,, Focal Adhesion-PI3K-Akt-mTOR-signaling pathway,Wikipathways,3,2ABB_HUMAN;CHAD_HUMAN;LAMB2_HUMAN,302 (302),0.406,1,, Epithelial cell signaling in Helicobacter pylori infection - Homo sapiens (human),KEGG,1,GIT1_HUMAN,68 (68),0.407,1,, Amphetamine addiction - Homo sapiens (human),KEGG,1,GNAS1_HUMAN,68 (68),0.407,1,, AMP-activated Protein Kinase (AMPK) Signaling,Wikipathways,1,PRGC2_HUMAN,68 (68),0.407,1,, Sterol Regulatory Element-Binding Proteins (SREBP) signalling,Wikipathways,1,PRGC2_HUMAN,68 (68),0.407,1,, Endoderm Differentiation,Wikipathways,1,CDC73_HUMAN,68 (71),0.407,1,, Dual incision in TC-NER,Reactome,1,RPB7_HUMAN,68 (69),0.407,1,, Tryptophan degradation,INOH,1,HCD2_HUMAN,69 (69),0.411,1,, TP53 Regulates Transcription of DNA Repair Genes,Reactome,1,RPB7_HUMAN,69 (70),0.411,1,, Plasma lipoprotein assembly_ remodeling_ and clearance,Reactome,1,CUBN_HUMAN,69 (69),0.411,1,, superpathway of inositol phosphate compounds,HumanCyc,1,PI5PA_HUMAN,69 (70),0.411,1,, Glycosphingolipid metabolism,EHMN,1,COPB2_HUMAN,69 (69),0.411,1,, Herpes simplex infection - Homo sapiens (human),KEGG,2,E2AK4_HUMAN;PER3_HUMAN,185 (185),0.414,1,, Calcium signaling pathway - Homo sapiens (human),KEGG,2,GNAS1_HUMAN;GRM5_HUMAN,185 (186),0.414,1,, RIG-I-like receptor signaling pathway - Homo sapiens (human),KEGG,1,AZI2_HUMAN,70 (70),0.416,1,, Prolactin signaling pathway - Homo sapiens (human),KEGG,1,SOCS7_HUMAN,70 (70),0.416,1,, Regulation of insulin secretion,Reactome,1,GNAS1_HUMAN,70 (70),0.416,1,, Alpha6Beta4Integrin,NetPath,1,LAMB2_HUMAN,70 (71),0.416,1,, Glucocorticoid Receptor Pathway,Wikipathways,1,MFGM_HUMAN,70 (71),0.416,1,, Intra-Golgi and retrograde Golgi-to-ER traffic,Reactome,2,KIF11_HUMAN;COPB2_HUMAN,186 (186),0.416,1,, Signaling by Rho GTPases,Reactome,4,RHG42_HUMAN;COF1_HUMAN;MYH9_HUMAN;SPN90_HUMAN,431 (435),0.418,1,, Cilium Assembly,Reactome,2,PCNT_HUMAN;AKAP9_HUMAN,187 (187),0.419,1,, CDC42 signaling events,PID,1,COF1_HUMAN,71 (71),0.42,1,, Bile secretion - Homo sapiens (human),KEGG,1,GNAS1_HUMAN,71 (71),0.42,1,, Clathrin derived vesicle budding,Reactome,1,NECP1_HUMAN,72 (72),0.425,1,, trans-Golgi Network Vesicle Budding,Reactome,1,NECP1_HUMAN,72 (72),0.425,1,, PKMTs methylate histone lysines,Reactome,1,NSD1_HUMAN,72 (73),0.425,1,, Arrhythmogenic right ventricular cardiomyopathy (ARVC) - Homo sapiens (human),KEGG,1,CACB1_HUMAN,72 (72),0.425,1,, Parkin-Ubiquitin Proteasomal System pathway,Wikipathways,1,SNCAP_HUMAN,72 (73),0.425,1,, Signaling by FGFR2,Reactome,1,RPB7_HUMAN,73 (73),0.429,1,, Transport of Mature mRNA derived from an Intron-Containing Transcript,Reactome,1,SLU7_HUMAN,73 (73),0.429,1,, Signaling by NOTCH1,Reactome,1,HDAC9_HUMAN,73 (74),0.429,1,, Bacterial invasion of epithelial cells - Homo sapiens (human),KEGG,1,SEPT3_HUMAN,74 (74),0.434,1,, Thyroid hormone synthesis - Homo sapiens (human),KEGG,1,GNAS1_HUMAN,74 (74),0.434,1,, Arrhythmogenic Right Ventricular Cardiomyopathy,Wikipathways,1,CACB1_HUMAN,74 (74),0.434,1,, Signaling by Nuclear Receptors,Reactome,2,PO2F1_HUMAN;RPB7_HUMAN,194 (195),0.437,1,, Transcriptional regulation by RUNX2,Reactome,1,PRGC2_HUMAN,75 (75),0.438,1,, E2F transcription factor network,PID,1,EST1_HUMAN,75 (75),0.438,1,, Gastric acid secretion - Homo sapiens (human),KEGG,1,GNAS1_HUMAN,75 (75),0.438,1,, Formation of the cornified envelope,Reactome,1,DSG4_HUMAN,75 (75),0.438,1,, DNA Repair,Reactome,3,DCR1B_HUMAN;RPB7_HUMAN;RD23B_HUMAN,318 (320),0.439,1,, Viral Acute Myocarditis,Wikipathways,1,ABL2_HUMAN,76 (76),0.442,1,, Transcription of the HIV genome,Reactome,1,RPB7_HUMAN,76 (77),0.442,1,, Pertussis - Homo sapiens (human),KEGG,1,COF1_HUMAN,76 (76),0.442,1,, Leptin signaling pathway,Wikipathways,1,SOCS7_HUMAN,76 (76),0.442,1,, RAF/MAP kinase cascade,Reactome,2,SPTN5_HUMAN;AKAP9_HUMAN,196 (197),0.442,1,, Focal Adhesion,Wikipathways,2,LAMB2_HUMAN;CHAD_HUMAN,198 (198),0.448,1,, Focal adhesion - Homo sapiens (human),KEGG,2,LAMB2_HUMAN;CHAD_HUMAN,199 (199),0.45,1,, cAMP signaling pathway - Homo sapiens (human),KEGG,2,GIPR_HUMAN;GNAS1_HUMAN,199 (199),0.45,1,, insulin,INOH,1,2ABB_HUMAN,78 (78),0.451,1,, Cardiac muscle contraction - Homo sapiens (human),KEGG,1,CACB1_HUMAN,78 (78),0.451,1,, Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide_ LLO) and transfer to a nascent protein,Reactome,1,SIA7F_HUMAN,78 (78),0.451,1,, Glycine_ serine_ alanine and threonine metabolism,EHMN,1,SYAM_HUMAN,78 (78),0.451,1,, Methionine and cysteine metabolism,EHMN,1,COPB2_HUMAN,78 (78),0.451,1,, Metabolism of RNA,Reactome,5,SNUT2_HUMAN;SRRM2_HUMAN;HCD2_HUMAN;SLU7_HUMAN;RPB7_HUMAN,577 (586),0.451,1,, Drug metabolism - other enzymes - Homo sapiens (human),KEGG,1,EST1_HUMAN,79 (79),0.455,1,, Protein ubiquitination,Reactome,1,CDC73_HUMAN,79 (80),0.455,1,, Alzheimers Disease,Wikipathways,1,HCD2_HUMAN,79 (145),0.455,1,, MAPK1/MAPK3 signaling,Reactome,2,SPTN5_HUMAN;AKAP9_HUMAN,202 (203),0.458,1,, Glucocorticoid receptor regulatory network,PID,1,PO2F1_HUMAN,80 (80),0.459,1,, Transcription-Coupled Nucleotide Excision Repair (TC-NER),Reactome,1,RPB7_HUMAN,80 (81),0.459,1,, Validated targets of C-MYC transcriptional activation,PID,1,PYR1_HUMAN,81 (87),0.463,1,, insulin Mam,INOH,1,2ABB_HUMAN,82 (82),0.467,1,, Amyloid fiber formation,Reactome,1,SNCAP_HUMAN,82 (82),0.467,1,, Transport of Mature Transcript to Cytoplasm,Reactome,1,SLU7_HUMAN,82 (82),0.467,1,, Peroxisome - Homo sapiens (human),KEGG,1,ADAS_HUMAN,83 (83),0.471,1,, Hypertrophic cardiomyopathy (HCM) - Homo sapiens (human),KEGG,1,CACB1_HUMAN,83 (83),0.471,1,, MicroRNAs in cardiomyocyte hypertrophy,Wikipathways,1,HDAC9_HUMAN,83 (102),0.471,1,, PI Metabolism,Reactome,1,PI5PA_HUMAN,84 (84),0.476,1,, Global Genome Nucleotide Excision Repair (GG-NER),Reactome,1,RD23B_HUMAN,84 (84),0.476,1,, GPCR ligand binding,Reactome,4,GIPR_HUMAN;P2Y11_HUMAN;GNAS1_HUMAN;GRM5_HUMAN,465 (466),0.476,1,, CXCR4-mediated signaling events,PID,1,COF1_HUMAN,85 (87),0.48,1,, Insulin secretion - Homo sapiens (human),KEGG,1,GNAS1_HUMAN,85 (85),0.48,1,, ErbB signaling pathway - Homo sapiens (human),KEGG,1,ABL2_HUMAN,85 (85),0.48,1,, PI3K-Akt Signaling Pathway,Wikipathways,3,LAMB2_HUMAN;CHAD_HUMAN;2ABB_HUMAN,339 (340),0.481,1,, Salmonella infection - Homo sapiens (human),KEGG,1,MYH9_HUMAN,86 (86),0.484,1,, Ciliary landscape,Wikipathways,2,NFM_HUMAN;NGAL_HUMAN,213 (213),0.485,1,, G alpha (q) signalling events,Reactome,2,P2Y11_HUMAN;GRM5_HUMAN,213 (213),0.485,1,, Signaling by FGFR,Reactome,1,RPB7_HUMAN,87 (87),0.488,1,, Protein-protein interactions at synapses,Reactome,1,GRM5_HUMAN,88 (88),0.491,1,, Mitochondrial translation initiation,Reactome,1,RM44_HUMAN,89 (89),0.495,1,, Mitochondrial translation elongation,Reactome,1,RM44_HUMAN,89 (89),0.495,1,, Mitochondrial translation termination,Reactome,1,RM44_HUMAN,89 (89),0.495,1,, Androgen and estrogen biosynthesis and metabolism,EHMN,1,COPB2_HUMAN,89 (89),0.495,1,, Platelet homeostasis,Reactome,1,GNAS1_HUMAN,89 (89),0.495,1,, Fc gamma R-mediated phagocytosis - Homo sapiens (human),KEGG,1,COF1_HUMAN,90 (91),0.499,1,, Salivary secretion - Homo sapiens (human),KEGG,1,GNAS1_HUMAN,90 (90),0.499,1,, Apoptosis Modulation and Signaling,Wikipathways,1,AIFM1_HUMAN,90 (91),0.499,1,, Cell Cycle_ Mitotic,Reactome,4,PCNT_HUMAN;NIPBL_HUMAN;AKAP9_HUMAN;PDS5B_HUMAN,479 (481),0.499,1,, ErbB Signaling Pathway,Wikipathways,1,ABL2_HUMAN,91 (92),0.503,1,, mRNA surveillance pathway - Homo sapiens (human),KEGG,1,2ABB_HUMAN,91 (91),0.503,1,, Amino Acid metabolism,Wikipathways,1,PYR1_HUMAN,91 (91),0.503,1,, GPCRs_ Other,Wikipathways,1,P2Y11_HUMAN,92 (101),0.507,1,, TNF alpha Signaling Pathway,Wikipathways,1,OTU7B_HUMAN,92 (93),0.507,1,, Corticotropin-releasing hormone signaling pathway,Wikipathways,1,GNAS1_HUMAN,92 (92),0.507,1,, PI3K-Akt signaling pathway - Homo sapiens (human),KEGG,3,2ABB_HUMAN;CHAD_HUMAN;LAMB2_HUMAN,353 (354),0.508,1,, Purine metabolism,EHMN,2,RPB7_HUMAN;COPB2_HUMAN,223 (223),0.51,1,, Small cell lung cancer - Homo sapiens (human),KEGG,1,LAMB2_HUMAN,93 (93),0.511,1,, GnRH signaling pathway - Homo sapiens (human),KEGG,1,GNAS1_HUMAN,93 (93),0.511,1,, Phosphatidylinositol phosphate metabolism,EHMN,1,COPB2_HUMAN,93 (93),0.511,1,, Interferon gamma signaling,Reactome,1,TRI29_HUMAN,94 (94),0.514,1,, B-WICH complex positively regulates rRNA expression,Reactome,1,MYO1C_HUMAN,94 (94),0.514,1,, Integration of energy metabolism,Reactome,1,GNAS1_HUMAN,94 (94),0.514,1,, Formation of the beta-catenin:TCF transactivating complex,Reactome,1,CDC73_HUMAN,94 (94),0.514,1,, Mitochondrial translation,Reactome,1,RM44_HUMAN,95 (95),0.518,1,, Aldosterone synthesis and secretion - Homo sapiens (human),KEGG,1,GNAS1_HUMAN,96 (96),0.522,1,, Pancreatic secretion - Homo sapiens (human),KEGG,1,GNAS1_HUMAN,96 (96),0.522,1,, RHO GTPases activate PKNs,Reactome,1,MYH9_HUMAN,96 (96),0.522,1,, Biological oxidations,Reactome,2,IMPA3_HUMAN;EST1_HUMAN,229 (231),0.524,1,, Thermogenesis - Homo sapiens (human),KEGG,2,NU4M_HUMAN;GNAS1_HUMAN,229 (229),0.524,1,, MAPK family signaling cascades,Reactome,2,SPTN5_HUMAN;AKAP9_HUMAN,234 (237),0.536,1,, Respiratory electron transport,Reactome,1,NU4M_HUMAN,100 (100),0.536,1,, Integrin-mediated Cell Adhesion,Wikipathways,1,CAN6_HUMAN,100 (101),0.536,1,, Potassium Channels,Reactome,1,KCNJ3_HUMAN,100 (100),0.536,1,, Melanogenesis - Homo sapiens (human),KEGG,1,GNAS1_HUMAN,101 (101),0.54,1,, Neural Crest Differentiation,Wikipathways,1,HDAC9_HUMAN,101 (101),0.54,1,, Wnt Signaling Pathway and Pluripotency,Wikipathways,1,2ABB_HUMAN,101 (101),0.54,1,, S Phase,Reactome,1,PDS5B_HUMAN,102 (103),0.544,1,, Visual phototransduction,Reactome,1,MYO7A_HUMAN,102 (102),0.544,1,, tRNA processing,Reactome,1,HCD2_HUMAN,103 (103),0.547,1,, Glucagon signaling pathway - Homo sapiens (human),KEGG,1,GNAS1_HUMAN,103 (103),0.547,1,, Electron Transport Chain (OXPHOS system in mitochondria),Wikipathways,1,NU4M_HUMAN,103 (103),0.547,1,, Liver steatosis AOP,Wikipathways,1,HCD2_HUMAN,103 (103),0.547,1,, Antimicrobial peptides,Reactome,1,NGAL_HUMAN,104 (106),0.551,1,, Metabolism of nucleotides,Reactome,1,PYR1_HUMAN,105 (105),0.554,1,, Degradation of the extracellular matrix,Reactome,1,CAN6_HUMAN,105 (105),0.554,1,, Transport of inorganic cations/anions and amino acids/oligopeptides,Reactome,1,SL9A2_HUMAN,105 (105),0.554,1,, Leukotriene metabolism,EHMN,1,HCD2_HUMAN,105 (105),0.554,1,, Parathyroid hormone synthesis_ secretion and action - Homo sapiens (human),KEGG,1,GNAS1_HUMAN,106 (106),0.557,1,, Endocytosis - Homo sapiens (human),KEGG,2,EP15R_HUMAN;GIT1_HUMAN,244 (244),0.559,1,, Insulin resistance - Homo sapiens (human),KEGG,1,PRGC2_HUMAN,107 (107),0.561,1,, Transcriptional regulation by small RNAs,Reactome,1,RPB7_HUMAN,107 (107),0.561,1,, Thermogenesis,Wikipathways,1,GNAS1_HUMAN,108 (108),0.564,1,, Diseases of signal transduction,Reactome,2,HDAC9_HUMAN;AKAP9_HUMAN,248 (248),0.567,1,, Positive epigenetic regulation of rRNA expression,Reactome,1,MYO1C_HUMAN,109 (109),0.568,1,, Phase I - Functionalization of compounds,Reactome,1,EST1_HUMAN,109 (109),0.568,1,, Resolution of Sister Chromatid Cohesion,Reactome,1,PDS5B_HUMAN,109 (109),0.568,1,, Cholinergic synapse - Homo sapiens (human),KEGG,1,KCNJ3_HUMAN,112 (112),0.577,1,, Phase II - Conjugation of compounds,Reactome,1,IMPA3_HUMAN,113 (115),0.581,1,, Toxoplasmosis - Homo sapiens (human),KEGG,1,LAMB2_HUMAN,113 (113),0.581,1,, Metabolism of water-soluble vitamins and cofactors,Reactome,1,CUBN_HUMAN,113 (114),0.581,1,, TGF-beta super family signaling pathway canonical,INOH,1,HDAC9_HUMAN,115 (115),0.587,1,, O-linked glycosylation,Reactome,1,C1GLT_HUMAN,116 (116),0.59,1,, Signaling by NOTCH,Reactome,1,HDAC9_HUMAN,117 (120),0.593,1,, Apoptosis,Reactome,1,ADDA_HUMAN,118 (118),0.597,1,, Sphingolipid signaling pathway - Homo sapiens (human),KEGG,1,2ABB_HUMAN,118 (118),0.597,1,, GPCR signaling-G alpha i,INOH,2,GNAS1_HUMAN;GRM5_HUMAN,262 (262),0.597,1,, GPCR signaling-pertussis toxin,INOH,2,GNAS1_HUMAN;GRM5_HUMAN,262 (262),0.597,1,, Glycosaminoglycan metabolism,Reactome,1,NDST1_HUMAN,119 (119),0.6,1,, AMPK signaling pathway - Homo sapiens (human),KEGG,1,2ABB_HUMAN,120 (120),0.603,1,, Programmed Cell Death,Reactome,1,ADDA_HUMAN,121 (121),0.606,1,, Vascular smooth muscle contraction - Homo sapiens (human),KEGG,1,GNAS1_HUMAN,121 (121),0.606,1,, Respiratory electron transport_ ATP synthesis by chemiosmotic coupling_ and heat production by uncoupling proteins.,Reactome,1,NU4M_HUMAN,123 (123),0.612,1,, Platelet activation - Homo sapiens (human),KEGG,1,GNAS1_HUMAN,123 (123),0.612,1,, GPCR signaling-cholera toxin,INOH,2,GNAS1_HUMAN;GRM5_HUMAN,270 (270),0.614,1,, GPCR signaling-G alpha s Epac and ERK,INOH,2,GNAS1_HUMAN;GRM5_HUMAN,272 (272),0.618,1,, Metabolism of steroids,Reactome,1,CUBN_HUMAN,127 (127),0.624,1,, PDGFR-beta signaling pathway,PID,1,2ABB_HUMAN,127 (127),0.624,1,, Autophagy - animal - Homo sapiens (human),KEGG,1,E2AK4_HUMAN,128 (128),0.627,1,, Separation of Sister Chromatids,Reactome,1,PDS5B_HUMAN,128 (129),0.627,1,, Cell Cycle,Reactome,4,NIPBL_HUMAN;PCNT_HUMAN;AKAP9_HUMAN;PDS5B_HUMAN,562 (564),0.627,1,, Keratinization,Reactome,1,DSG4_HUMAN,129 (129),0.629,1,, Signaling by Receptor Tyrosine Kinases,Reactome,3,LAMB2_HUMAN;RPB7_HUMAN;EP15R_HUMAN,423 (423),0.631,1,, Relaxin signaling pathway - Homo sapiens (human),KEGG,1,GNAS1_HUMAN,130 (130),0.632,1,, Ebola Virus Pathway on Host,Wikipathways,1,MFGM_HUMAN,130 (130),0.632,1,, Measles - Homo sapiens (human),KEGG,1,E2AK4_HUMAN,131 (132),0.635,1,, Oxidative phosphorylation - Homo sapiens (human),KEGG,1,NU4M_HUMAN,133 (133),0.641,1,, GPCR signaling-G alpha s PKA and ERK,INOH,2,GNAS1_HUMAN;GRM5_HUMAN,285 (285),0.643,1,, Apoptosis - Homo sapiens (human),KEGG,1,AIFM1_HUMAN,136 (136),0.649,1,, Death Receptor Signalling,Reactome,1,OTU7B_HUMAN,138 (141),0.654,1,, Mitotic Anaphase,Reactome,1,PDS5B_HUMAN,139 (140),0.657,1,, Ectoderm Differentiation,Wikipathways,1,C1GLT_HUMAN,139 (142),0.657,1,, Extracellular matrix organization,Reactome,2,LAMB2_HUMAN;CAN6_HUMAN,293 (294),0.658,1,, Rho GTPase cycle,Reactome,1,RHG42_HUMAN,140 (144),0.66,1,, Mitotic Metaphase and Anaphase,Reactome,1,PDS5B_HUMAN,140 (141),0.66,1,, Late Phase of HIV Life Cycle,Reactome,1,RPB7_HUMAN,141 (143),0.662,1,, Direct p53 effectors,PID,1,DGCR8_HUMAN,142 (143),0.665,1,, NRF2 pathway,Wikipathways,1,EST1_HUMAN,142 (142),0.665,1,, AndrogenReceptor,NetPath,1,NSD1_HUMAN,143 (143),0.668,1,, Translation,Reactome,2,RM44_HUMAN;SYAM_HUMAN,299 (310),0.669,1,, Cell adhesion molecules (CAMs) - Homo sapiens (human),KEGG,1,CD226_HUMAN,144 (144),0.67,1,, Brain-Derived Neurotrophic Factor (BDNF) signaling pathway,Wikipathways,1,COF1_HUMAN,144 (144),0.67,1,, Epigenetic regulation of gene expression,Reactome,1,MYO1C_HUMAN,151 (151),0.688,1,, HIV Life Cycle,Reactome,1,RPB7_HUMAN,154 (156),0.695,1,, Hippo signaling pathway - Homo sapiens (human),KEGG,1,2ABB_HUMAN,154 (154),0.695,1,, Cushing syndrome - Homo sapiens (human),KEGG,1,GNAS1_HUMAN,154 (154),0.695,1,, Myometrial Relaxation and Contraction Pathways,Wikipathways,1,GNAS1_HUMAN,155 (155),0.697,1,, Nuclear Receptors Meta-Pathway,Wikipathways,2,MFGM_HUMAN;EST1_HUMAN,315 (316),0.697,1,, Interferon Signaling,Reactome,1,TRI29_HUMAN,158 (158),0.704,1,, Insulin Signaling,Wikipathways,1,MYO1C_HUMAN,160 (160),0.709,1,, JAK-STAT signaling pathway - Homo sapiens (human),KEGG,1,SOCS7_HUMAN,162 (162),0.713,1,, Necroptosis - Homo sapiens (human),KEGG,1,AIFM1_HUMAN,162 (162),0.713,1,, Metabolism of amino acids and derivatives,Reactome,2,DUOX1_HUMAN;HCD2_HUMAN,330 (342),0.721,1,, Alzheimer disease - Homo sapiens (human),KEGG,1,HCD2_HUMAN,171 (171),0.732,1,, Influenza A - Homo sapiens (human),KEGG,1,E2AK4_HUMAN,171 (171),0.732,1,, The citric acid (TCA) cycle and respiratory electron transport,Reactome,1,NU4M_HUMAN,173 (173),0.737,1,, Purine metabolism - Homo sapiens (human),KEGG,1,RPB7_HUMAN,173 (174),0.737,1,, Signal Transduction,Reactome,18,RHG42_HUMAN;EP15R_HUMAN;GRM5_HUMAN;SPTN5_HUMAN;HDAC9_HUMAN;MYO7A_HUMAN;P2Y11_HUMAN;LAMB2_HUMAN;PO2F1_HUMAN;SPN90_HUMAN;COF1_HUMAN;GIPR_HUMAN;MYH9_HUMAN;CDC73_HUMAN;GNAS1_HUMAN;RPB7_HUMAN;OTU7B_HUMAN;AKAP9_HUMAN,2634 (2647),0.738,1,, Disease,Reactome,3,RPB7_HUMAN;AKAP9_HUMAN;HDAC9_HUMAN,508 (510),0.75,1,, Metabolism of vitamins and cofactors,Reactome,1,CUBN_HUMAN,180 (181),0.75,1,, Metapathway biotransformation Phase I and II,Wikipathways,1,NDST1_HUMAN,184 (186),0.758,1,, Ras Signaling,Wikipathways,1,ABL2_HUMAN,184 (184),0.758,1,, TCF dependent signaling in response to WNT,Reactome,1,CDC73_HUMAN,189 (190),0.767,1,, Pathways in cancer - Homo sapiens (human),KEGG,3,LAMB2_HUMAN;GNAS1_HUMAN;TFG_HUMAN,525 (526),0.77,1,, HIV Infection,Reactome,1,RPB7_HUMAN,195 (197),0.778,1,, Viral carcinogenesis - Homo sapiens (human),KEGG,1,HDAC9_HUMAN,201 (201),0.788,1,, Rap1 signaling pathway - Homo sapiens (human),KEGG,1,GNAS1_HUMAN,206 (206),0.796,1,, Human immunodeficiency virus 1 infection - Homo sapiens (human),KEGG,1,COF1_HUMAN,212 (212),0.805,1,, Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,Reactome,1,CD226_HUMAN,214 (221),0.808,1,, Phospholipid metabolism,Reactome,1,PI5PA_HUMAN,215 (216),0.81,1,, G alpha (i) signalling events,Reactome,2,GNAS1_HUMAN;MYO7A_HUMAN,399 (400),0.813,1,, Ub-specific processing proteases,Reactome,1,UBP25_HUMAN,220 (220),0.817,1,, Human cytomegalovirus infection - Homo sapiens (human),KEGG,1,GNAS1_HUMAN,225 (225),0.824,1,, G alpha (s) signalling events,Reactome,3,GIPR_HUMAN;P2Y11_HUMAN;GNAS1_HUMAN,581 (583),0.826,1,, Gene expression (Transcription),Reactome,8,MYO1C_HUMAN;MGAP_HUMAN;SLU7_HUMAN;PO2F1_HUMAN;PRGC2_HUMAN;DGCR8_HUMAN;CDC73_HUMAN;RPB7_HUMAN,1360 (1373),0.828,1,, Ras signaling pathway - Homo sapiens (human),KEGG,1,ABL2_HUMAN,232 (232),0.834,1,, TNFalpha,NetPath,1,COPB2_HUMAN,234 (234),0.836,1,, Neddylation,Reactome,1,FBX9_HUMAN,234 (235),0.836,1,, SLC-mediated transmembrane transport,Reactome,1,SL9A2_HUMAN,244 (245),0.848,1,, MAPK Signaling Pathway,Wikipathways,1,CACB1_HUMAN,246 (246),0.851,1,, Infectious disease,Reactome,1,RPB7_HUMAN,251 (253),0.857,1,, GPCRs_ Class A Rhodopsin-like,Wikipathways,1,P2Y11_HUMAN,260 (261),0.866,1,, Antigen processing: Ubiquitination & Proteasome degradation,Reactome,1,FBX9_HUMAN,261 (264),0.867,1,, Metabolism of carbohydrates,Reactome,1,NDST1_HUMAN,263 (264),0.869,1,, miR-targeted genes in epithelium - TarBase,Wikipathways,1,RD23B_HUMAN,267 (333),0.873,1,, Chromatin modifying enzymes,Reactome,1,NSD1_HUMAN,271 (272),0.877,1,, Chromatin organization,Reactome,1,NSD1_HUMAN,271 (272),0.877,1,, GPCR signaling-G alpha q,INOH,1,GRM5_HUMAN,274 (274),0.88,1,, Signaling by WNT,Reactome,1,CDC73_HUMAN,277 (278),0.883,1,, Metabolism of lipids,Reactome,3,PI5PA_HUMAN;ADAS_HUMAN;CUBN_HUMAN,660 (664),0.886,1,, Neutrophil degranulation,Reactome,2,AACT_HUMAN;NGAL_HUMAN,488 (490),0.892,1,, Metabolism,Reactome,11,EST1_HUMAN;NDST1_HUMAN;CUBN_HUMAN;IMPA3_HUMAN;DUOX1_HUMAN;PI5PA_HUMAN;PYR1_HUMAN;HCD2_HUMAN;GNAS1_HUMAN;ADAS_HUMAN;NU4M_HUMAN,1954 (1972),0.898,1,, MAPK signaling pathway - Homo sapiens (human),KEGG,1,CACB1_HUMAN,295 (295),0.898,1,, RNA Polymerase II Transcription,Reactome,6,MGAP_HUMAN;SLU7_HUMAN;PO2F1_HUMAN;PRGC2_HUMAN;CDC73_HUMAN;RPB7_HUMAN,1223 (1236),0.915,1,, Class I MHC mediated antigen processing & presentation,Reactome,1,FBX9_HUMAN,321 (324),0.917,1,, miR-targeted genes in muscle cell - TarBase,Wikipathways,1,RD23B_HUMAN,329 (400),0.922,1,, Class A/1 (Rhodopsin-like receptors),Reactome,1,P2Y11_HUMAN,330 (330),0.923,1,, Transcriptional Regulation by TP53,Reactome,1,RPB7_HUMAN,372 (374),0.945,1,, GPCR downstream signalling,Reactome,5,GIPR_HUMAN;P2Y11_HUMAN;GNAS1_HUMAN;GRM5_HUMAN;MYO7A_HUMAN,1172 (1176),0.952,1,, miR-targeted genes in lymphocytes - TarBase,Wikipathways,1,RD23B_HUMAN,409 (489),0.959,1,, Signaling by GPCR,Reactome,5,GIPR_HUMAN;P2Y11_HUMAN;GNAS1_HUMAN;GRM5_HUMAN;MYO7A_HUMAN,1235 (1240),0.965,1,, Innate Immune System,Reactome,4,COF1_HUMAN;AACT_HUMAN;SPN90_HUMAN;NGAL_HUMAN,1067 (1077),0.968,1,, Cytokine Signaling in Immune system,Reactome,1,TRI29_HUMAN,458 (458),0.972,1,, Adaptive Immune System,Reactome,2,CD226_HUMAN;FBX9_HUMAN,722 (732),0.977,1,, Immune System,Reactome,7,TRI29_HUMAN;CD226_HUMAN;AACT_HUMAN;COF1_HUMAN;FBX9_HUMAN;SPN90_HUMAN;NGAL_HUMAN,1825 (1840),0.99,1,, Generic Transcription Pathway,Reactome,3,PRGC2_HUMAN;RPB7_HUMAN;MGAP_HUMAN,1101 (1107),0.992,1,,